← Back to Search
Management Guidelines For Children With Thyroid Nodules And Differentiated Thyroid Cancer.
G. Francis, S. Waguespack, A. Bauer, P. Angelos, S. Benvenga, J. Cerutti, C. Dinauer, J. Hamilton, I. Hay, M. Luster, M. Parisi, M. Rachmiel, G. Thompson, S. Yamashita
Published 2015 · Medicine
Save to my Library
Download via 🐼 PaperPanda Download via oaDOI Download via OAB Download via LibKey Download via Google Google ScholarAnalyze on Scholarcy Visualize in Litmaps
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
BACKGROUND Previous guidelines for the management of thyroid nodules and cancers were geared toward adults. Compared with thyroid neoplasms in adults, however, those in the pediatric population exhibit differences in pathophysiology, clinical presentation, and long-term outcomes. Furthermore, therapy that may be recommended for an adult may not be appropriate for a child who is at low risk for death but at higher risk for long-term harm from overly aggressive treatment. For these reasons, unique guidelines for children and adolescents with thyroid tumors are needed. METHODS A task force commissioned by the American Thyroid Association (ATA) developed a series of clinically relevant questions pertaining to the management of children with thyroid nodules and differentiated thyroid cancer (DTC). Using an extensive literature search, primarily focused on studies that included subjects ≤18 years of age, the task force identified and reviewed relevant articles through April 2014. Recommendations were made based upon scientific evidence and expert opinion and were graded using a modified schema from the United States Preventive Services Task Force. RESULTS These inaugural guidelines provide recommendations for the evaluation and management of thyroid nodules in children and adolescents, including the role and interpretation of ultrasound, fine-needle aspiration cytology, and the management of benign nodules. Recommendations for the evaluation, treatment, and follow-up of children and adolescents with DTC are outlined and include preoperative staging, surgical management, postoperative staging, the role of radioactive iodine therapy, and goals for thyrotropin suppression. Management algorithms are proposed and separate recommendations for papillary and follicular thyroid cancers are provided. CONCLUSIONS In response to our charge as an independent task force appointed by the ATA, we developed recommendations based on scientific evidence and expert opinion for the management of thyroid nodules and DTC in children and adolescents. In our opinion, these represent the current optimal care for children and adolescents with these conditions.
This paper references
Pathological report of a case of acromegaly with especial reference to the lesions in the hypophysis cerebri and in the thyroid gland ; and a case of hemorrhage into the pituitary
P. Bailey (1898)
Z. Hall (1906)
P. Desaive (1951)
The iodine-deficient human thyroid gland; a preliminary report.
J. Stanbury (1952)
Yaciofano AC 1952 The iodine-deficient human thyroid gland; a preliminary report. The Journal of clinical endocrinology and metabolism 12:191-207
JB Stanbury (1952)
Cancer; a review.
M. Knapp (1956)
The relation of radioiodine dosimetry to results and complications in the treatment of metastatic thyroid cancer.
R. Benua (1962)
Acromegaly: a review of 100 cases.
D. Gordon (1962)
STRUCTURAL CHANGES IN THE THYROID GLANDS OF HEALTHY YOUNG MEN.
J. Oertel (1965)
[THYROID CANCER IN CHILDREN].
C. Dufourmentel (1965)
STRUCTURAL CHANGES IN THE THYROID GLANDS OF HEALTHY YOUNG MEN.
Oertel Je (1965)
Changes of carbohydrate tolerance in acromegaly with progress of the disease and in response to treatment.
P. Sönksen (1967)
Calcium Metabolism in Acromegaly
A. Nadarajah (1968)
A glucose-responsive insulinoma.
L. Power (1969)
Lack of Glucagon Response to Hypoglycemia in Diabetes: Evidence for an Intrinsic Pancreatic Alpha Cell Defect
J. Gerich (1973)
Source of Estrogen Production in Postmenopausal Women
J. Grodin (1973)
Menopausal age and symptomatology in a general practice.
B. Thompson (1973)
Clinical and laboratory study of acromegaly: assessment before and one year after treatment.
J. Kanis (1974)
Suppressive therapy of nontoxic goiter.
K. Shimaoka (1974)
Factitial hypoglycemia. Three cases diagnosed on the basis of insulin antibodies.
F. J. Service (1974)
Suppressive therapy of nontoxic goiter. The American journal of medicine 57:576-583
K Shimaoka (1974)
Estriol prevention of mammary carcinoma induced by 7,12-dimethylbenzanthracene and procarbazine.
H. Lemon (1975)
Clofibrate and niacin in coronary heart disease.
J. Stamler (1975)
Serum lipids in acromegaly.
E. Nikkilä (1975)
Insulinoma: clinical and diagnostic features of 60 consecutive cases.
Dale Aj (1976)
ENDOCRINE CHANGES AND SYMPTOMATOLOGY AFTER OOPHORECTOMY IN PREMENOPAUSAL WOMEN
S. Chakravarti (1977)
Factitious hypoglycemia. Diagnosis by measurement of serum C-peptide immunoreactivity and insulin-binding antibodies.
J. A. Scarlett (1977)
Pituitary apoplexy. Association of degenerative change in pituitary ademona with radiotherapy and detection by cerebral computed tomography.
L. Weisberg (1977)
Radioimmunoassay of human thyroglobulin: effect of antithyroglobulin autoantibodies.
A. Schneider (1978)
Acromegaly and narcolepsy.
P. Rees (1979)
Evaluation of acromegaly by radioimmunoassay of somatomedin-C.
D. Clemmons (1979)
Acromegaly and vitamin D metabolism: effect of bromocriptine treatment.
P. Eskildsen (1979)
Comparison of the distribution of diagnostic and thyroablative I-131 in the evaluation of differentiated thyroid cancers.
J. Němec (1979)
Systemic absorption and sustained effects of vaginal estrogen creams.
P. L. Martin (1979)
Bromocriptine for an acromegalic patient. Improvement in cardiac function and carpal tunnel syndrome.
R. Luboshitzky (1980)
Clonidine (Dixarit) for menopausal flushing.
R. Edington (1980)
Estradiol treatment of acromegaly. Reduction of immunoreactive somatomedin-C and improvement in metabolic status.
D. Clemmons (1980)
Myxomatous degeneration and cystic medial necrosis associated with acromegaly.
S. Ondreyco (1980)
Oral medroxyprogesterone in the treatment of postmenopausal symptoms.
I. Schiff (1980)
Calcium and vitamin D metabolism in acromegaly.
B. Lund (1981)
Severe insulin-induced hypoglycemia associated with deficiencies in the release of counterregulatory hormones.
G. Boden (1981)
Pathogenesis of Hypoglycemia in Insulinoma Patients: Suppression of Hepatic Glucose Production by Insulin
R. Rizza (1981)
Effect of Clonidine on Hot Flashes in Postmenopausal Women
L. Laufer (1982)
Histochemical characterization of the cutaneous involvement of acromegaly.
L. Matsuoka (1982)
The Acromegaly Syndrome
A. Jadresic (1982)
Somatomedins in pregnancy: a cross-sectional study of insulin-like growth factors I and II and somatomedin peptide content in normal human pregnancies.
D. Wilson (1982)
Differential effects of endocrine dysfunction on the axial and the appendicular skeleton.
E. Seeman (1982)
Effect of Oral Medroxyprogesterone Acetate on Menopausal Symptoms in Patients with Endometrial Carcinoma
K. Aslaksen (1982)
Coincidental pituitary adenoma and cerebral aneurysm with pathological findings.
J. Mangiardi (1983)
Identification of type I diabetic patients at increased risk for hypoglycemia during intensive therapy.
N. White (1983)
Oral glucose tolerance test compared with a mixed meal in the diagnosis of reactive hypoglycemia. A caveat on stimulation.
Hogan Mj (1983)
Abnormal Glucose Counterregulation in Insulin-dependent Diabetes Mellitus: Interaction of Anti-Insulin Antibodies and Impaired Glucagon and Epinephrine Secretion
G. Bolli (1983)
Visual status after transsphenoidal surgery at the Mayo Clinic, 1971-1982.
J. Trautmann (1983)
Hyperinsulinaemic hypoglycaemia due to chlorpropamide-induced nesidioblastosis.
G. Rayman (1984)
A Reliable and Reproducible Test for Adequate Glucose Counterregulation in Type I Diabetes Mellitus
G. Bolli (1984)
Long-term treatment of acromegaly with the somatostatin analogue SMS 201-995.
S. Lamberts (1985)
Changes in calcium homeostasis in acromegaly treated by pituitary adenomectomy.
S. Takamoto (1985)
NEUROENDOCRINOLOGY OF MENOPAUSAL FLUSHES: AN HYPOTHESIS OF FLUSH MECHANISM
R. Casper (1985)
Serum thyroglobulin (Tg) in presence of thyroglobulin autoantibodies (TgAb). Clinical and methodological relevance of the interaction between Tg and TgAb in vitro and in vivo
U. Feldt-Rasmussen (1985)
Side effects of "rational dose" iodine-131 therapy for metastatic well-differentiated thyroid carcinoma.
D. van Nostrand (1986)
Risk Factors in Follicular Thyroid Carcinomas: A Retrospective Follow-up Study Covering a 14-Year Period with Emphasis on Morphological Findings
W. Lang (1986)
Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin.
P. Canner (1986)
The long-term hazards of the treatment of thyroid cancer with radioiodine.
C. Edmonds (1986)
Acromegalic arthropathy: a reversible rheumatic disease.
S. Lacks (1986)
Oedema of the neck after ablation of the thyroid with radioactive iodine.
A. Goolden (1986)
RAPID IMPROVEMENT IN SLEEP APNOEA OF ACROMEGALY AFTER SHORT-TERM TREATMENT WITH SOMATOSTATIN ANALOGUE SMS 201-995
P. Chanson (1986)
Reversible hypopituitarism in patients with large nonfunctioning pituitary adenomas.
B. Arafah (1986)
Acromegaly and resulting myofascial pain and temporomandibular joint dysfunction: review of the literature and report of case.
R. E. Hampton (1987)
SLEEP APNOEA AND DAYTIME SLEEPINESS IN ACROMEGALY: RELATIONSHIP TO ENDOCRINOLOGICAL FACTORS
T. Pekkarinen (1987)
Treatment of menopausal hot flashes with transdermal administration of clonidine.
M. Nagamani (1987)
Differentiated thyroid carcinoma in childhood: long term follow-up of 72 patients.
M. Schlumberger (1987)
Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.
M. Frick (1987)
Autonomously functioning thyroid nodules in childhood and adolescence.
R. Croom (1987)
Hypertriglyceridemia: a contraindication to the use of bile acid binding resins.
J. Crouse (1987)
Differentiated thyroid carcinoma in childhood: long term follow-up of 72 patients. The Journal of clinical endocrinology and metabolism 65:1088-1094
M Schlumberger (1987)
Low-density lipoprotein subclass patterns and risk of myocardial infarction.
M. Austin (1988)
Recurrence and morbidity in differentiated thyroid carcinoma in children.
M. La Quaglia (1988)
Papillary thyroid carcinoma in children and adults: long-term follow-up of 1039 patients conservatively treated at one institution during three decades.
D. Zimmerman (1988)
The physiology of growth hormones (GHs) in pregnant women and partial characterization of the placental GH variant.
F. Frankenne (1988)
Factitious hypoglycemia due to surreptitious administration of insulin. Diagnosis, treatment, and long-term follow-up.
G. Grunberger (1988)
Correlation Between Minimal Secretory Capacity of Pancreatic β-Cells and Stability of Diabetic Control
M. Fukuda (1988)
Detection and treatment of lung metastases of differentiated thyroid carcinoma in patients with normal chest X-rays.
M. Schlumberger (1988)
Role of Insulin Resistance in Human Disease
G. Reaven (1988)
Veralipride: alternative antidopaminergic treatment for menopausal symptoms.
A. David (1988)
Papillary thyroid carcinoma in children and adults: long-term follow-up of 1039 patients conservatively treated at one institution during three decades. Surgery 104:11571166
D Zimmerman (1988)
Papillary thyroid carcinoma in children and adults: long-term follow-up of 1039 patients conservatively treated at one institution during three decades. Surgery 104:1157–1166
D Zimmerman (1988)
NIH conference. Somatostatin and somatostatin analogue (SMS 201-995) in treatment of hormone-secreting tumors of the pituitary and gastrointestinal tract and non-neoplastic diseases of the gut.
P. Gorden (1989)
Recurrence of thyroid nodules after surgical removal in patients irradiated in childhood for benign conditions.
L. Fogelfeld (1989)
Sodium restriction and blood pressure in hypertensive type II diabetics: randomised blind controlled and crossover studies of moderate sodium restriction and sodium supplementation.
P. Dodson (1989)
Hypopituitarism following external radiotherapy for pituitary tumours in adults.
M. Littley (1989)
Increased blood pressure during potassium depletion in normotensive men.
G. G. Krishna (1989)
On the usefulness of levothyroxine suppressive therapy in the medical treatment of benign solitary, solid or predominantly solid, thyroid nodules.
M. Celani (1990)
Radioactive iodine therapy: Effect on functioning metastases ofadenocarcinoma of the thyroid
S. M. Seidlin (1990)
Growth hormone responses to oral glucose loading measured by highly sensitive enzyme immunoassay in normal subjects and patients with glucose intolerance and acromegaly.
N. Hattori (1990)
Natural history, treatment, and course of papillary thyroid carcinoma.
L. Degroot (1990)
Acromegaly and primary amenorrhea: ovulation and pregnancy induced by SMS 201–995 and bromocriptine
M. Montini (1990)
Lymph node metastasis from papillary-follicular thyroid carcinoma in young patients.
R. Frankenthaler (1990)
Does Physical Exercise Influence the Frequency of Postmenopausal Hot Flushes?
M. Hammar (1990)
Placental and pituitary growth hormone secretion during pregnancy in acromegalic women.
A. Beckers (1990)
Potassium depletion exacerbates essential hypertension.
G. G. Krishna (1991)
Reduced Neuroendocrine and Symptomatic Responses to Subsequent Hypoglycemia After 1 Episode of Hypoglycemia in Nondiabetic Humans
S. Heller (1991)
Typical changes in the viscerocranium in acromegaly.
A. Künzler (1991)
Insulinomas: localization with selective intraarterial injection of calcium.
J. Doppman (1991)
Functioning insulinoma--incidence, recurrence, and long-term survival of patients: a 60-year study.
F. J. Service (1991)
Therapeutic radiation at a young age is linked to secondary thyroid cancer. The Late Effects Study Group.
M. Tucker (1991)
Unexplained Deaths of Type 1 Diabetic Patients
R. Tattersall (1991)
Differentiated thyroid carcinomas in children and adolescents
A. M. Samuel (1991)
Follicular thyroid carcinoma with capsular invasion alone: a nonthreatening malignancy.
J. V. van Heerden (1992)
MODULATION OF MENOPAUSAL HOT FLASHES BY AMBIENT TEMPERATURE
F. Kronenberg (1992)
Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma.
M. Brada (1992)
Joint Effects of Serum Triglyceride and LDL Cholesterol and HDL Cholesterol Concentrations on Coronary Heart Disease Risk in the Helsinki Heart Study: Implications for Treatment
Vesa Manninen (1992)
Radioiodine-131 therapy for well-differentiated thyroid cancer--a quantitative radiation dosimetric approach: outcome and validation in 85 patients.
H. Maxon (1992)
Further Defects in Counterregulatory Responses Induced by Recurrent Hypoglycemia in IDDM
M. Davis (1992)
Influence of antibodies against IGF-I, insulin or their receptors on proliferation of human acute lymphoblastic leukemia cell lines.
T. Baier (1992)
Basal- and insulin-stimulated substrate metabolism in patients with active acromegaly before and after adenomectomy.
N. Møller (1992)
Reirradiation of pituitary adenoma
R. Schoenthaler (1992)
Arrhythmia profile in acromegaly.
G. Kahaly (1992)
Alanine and Terbutaline in Treatment of Hypoglycemia in IDDM
B. V. Wiethop (1993)
Psychosomatic view of endocrine disorders.
G. Fava (1993)
Meticulous Prevention of Hypoglycemia Normalizes the Glycemic Thresholds and Magnitude of Most of Neuroendocrine Responses to, Symptoms of, and Cognitive Function During Hypoglycemia in Intensively Treated Patients With Short-Term IDDM
C. Fanelli (1993)
Octreotide reverses hyperinsulinemia and prevents hypoglycemia induced by sulfonylurea overdoses.
P. Boyle (1993)
A retrospective analysis of pituitary apoplexy.
D. Bills (1993)
Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia.
S. Dagogo-Jack (1993)
MR of the pituitary gland postsurgery: serial MR studies following transsphenoidal resection.
T. Dina (1993)
Long-term echocardiographic follow-up of acromegalic heart disease.
J. Hradec (1993)
The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long‐Term Complications in Insulin‐Dependent Diabetes Mellitus
D. Nathan (1993)
Management of a solitary thyroid nodule.
E. Mazzaferri (1993)
Results of surgical treatment for growth hormone-secreting pituitary adenomas.
D. Davis (1993)
Pulmonary metastases in children and young adults with differentiated thyroid cancer
R. Vassilopoulou-sellin (1993)
An audit of outcome of treatment in acromegaly.
A. Bates (1993)
Glioma arising after radiation therapy for pituitary adenoma. A report of four patients and estimation of risk
R. Tsang (1993)
Radiation therapy for pituitary adenoma: treatment outcome and prognostic factors.
R. Tsang (1994)
ITT and IGF-I in the diagnosis of growth hormone deficiency in adults
D. Hoffman (1994)
Reversal of Hypoglycemia Unawareness, But Not Defective Glucose Counterregulation, in IDDM
S. Dagogo-Jack (1994)
Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes
I. Cranston (1994)
F. Iida (1994)
Frequency of Severe Hypoglycemia in Patients With Type I Diabetes With Impaired Awareness of Hypoglycemia
A. Gold (1994)
Testicular function in patients with differentiated thyroid carcinoma treated with radioiodine.
F. Pacini (1994)
The Efficacy of Acarbose in the Treatment of Patients with NonInsulin-Dependent Diabetes Mellitus: A Multicenter, Controlled Clinical Trial
J. Chiasson (1994)
Megestrol acetate for the prevention of hot flashes.
C. Loprinzi (1994)
Blood supply of the parathyroid gland from the superior thyroid artery.
M. Nobori (1994)
Enhanced sensitivity growth hormone (GH) chemiluminescence assay reveals lower postglucose nadir GH concentrations in men than women.
I. Chapman (1994)
Significance of antithyroglobulin autoantibodies in differentiated thyroid carcinoma.
A. Kumar (1994)
Reduction in blood pressure with a low sodium, high potassium, high magnesium salt in older subjects with mild to moderate hypertension
J. Geleijnse (1994)
Changes in bone mass during prolonged subclinical hyperthyroidism due to L-thyroxine treatment: a meta-analysis.
J. Faber (1994)
Chromosome aberrations after treatment with radioactive iodine for thyroid cancer.
L. Baugnet-Mahieu (1994)
Mortality and Treatment Side-Effects During Long-Term Intensified Conventional Insulin Treatment in the Stockholm Diabetes Intervention Study
P. Reichard (1994)
Assessment of the influence of thyroglobulin (Tg) autoantibodies and other interfering factors on the use of serum Tg as tumor marker in differentiated thyroid carcinoma.
B. Schaadt (1995)
Childhood thyroid cancer in England and Wales.
H. R. Harach (1995)
Epidemiology faces its limits.
G. Taubes (1995)
Evaluation and management of the solid thyroid nodule.
H. Burch (1995)
Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
J. Shepherd (1995)
Delayed hyponatremia after transsphenoidal surgery for pituitary adenoma. Report of nine cases.
D. Kelly (1995)
Prevalence of menopausal symptoms among women with a history of breast cancer and attitudes toward estrogen replacement therapy.
R. Couzi (1995)
Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.
Y. Ohkubo (1995)
Calcium intake and blood pressure: epidemiology revisited.
Morris Cd (1995)
Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies.
E. Ron (1995)
The prevalence of colonic polyps in acromegaly: a colonoscopic and pathological study in 103 patients.
B. Delhougne (1995)
Feasibility of the association of mitotane with etoposide, adriamycin and cisplatin combination chemotherapy in advanced adrenocortical cancer patients. Report on 7 cases.
A. Pia (1995)
Variation in Patient Utilities for Outcomes of the Management of Chronic Stable Angina: Implications for Clinical Practice Guidelines
R. Nease (1995)
Childhood thyroid diseases around Chernobyl evaluated by ultrasound examination and fine needle aspiration cytology.
M. Ito (1995)
In vivo responsiveness of morphological variants of growth hormone-producing pituitary adenomas to octreotide.
S. Ezzat (1995)
Maternal-fetal transfer of octreotide.
P. Caron (1995)
Evaluation and management of the solid thyroid nodule. Endocrinology and metabolism clinics of North America 24:663-710
HB Burch (1995)
LINAC-radiosurgery (LINAC-RS) in pituitary adenomas: preliminary results.
J. Voges (1996)
Prediction of efficacy of octreotide therapy in patients with acromegaly.
A. Colao (1996)
Implantable insulin pump vs multiple-dose insulin for non-insulin-dependent diabetes mellitus: a randomized clinical trial. Department of Veterans Affairs Implantable Insulin Pump Study Group.
C. Saudek (1996)
Insulin-like growth factor-I (IGF-I) and IGF-binding proteins in children with nephrotic syndrome.
D. Y. Lee (1996)
Thyroid cancer in children, pregnant women, and patients with Graves' disease.
D. McClellan (1996)
Serum levels of sex hormones, thyroid hormones, growth hormone, IGF I, and cortisol and their relations to body fat distribution in healthy women dependent on their menopausal status.
S. Kirchengast (1996)
Regulation of the insulin-like growth factor system by insulin in burn patients.
C. Lang (1996)
Fates worse than death: the role of valued life activities in health-state evaluations.
P. Ditto (1996)
Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Québec cardiovascular study.
B. Lamarche (1996)
Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. American Thyroid Association.
P. Singer (1996)
Assessment of functional liver mass and plasma flow in acromegaly before and after long-term treatment with octreotide.
P. Avagnina (1996)
Thyroid Cancer Detected by Ultrasound-Guided Fine-Needle Aspiration Biopsy
T. Yokozawa (1996)
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.
F. Sacks (1996)
The comparative effect on bone density, endometrium, and lipids of continuous hormones as replacement therapy (CHART study). A randomized controlled trial.
L. Speroff (1996)
Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. American Thyroid Association.
P. Singer (1996)
Treatment guidelines for patients with thyroid nodules and welldifferentiated thyroid cancer
PA Singer (1996)
Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials.
P. Whelton (1997)
The thyroid gland in acromegaly: an ultrasonographic study
N. Cheung (1997)
Contribution of Autonomic Neuropathy to Reduced Plasma Adrenaline Responses to Hypoglycemia in IDDM: Evidence for a Nonselective Defect
P. Bottini (1997)
Differentiated thyroid carcinoma in children and adolescents: a 37-year experience in 85 patients.
M. Dottorini (1997)
Treatment of menopausal symptoms with applied relaxation: a pilot study.
K. Wijma (1997)
Characteristics of differentiated thyroid carcinoma in children and adolescents with respect to age, gender, and histology
J. Farahati (1997)
Pituitary irradiation is ineffective in normalizing plasma insulin-like growth factor I in patients with acromegaly.
A. Barkan (1997)
Intraarterial calcium stimulation and intraoperative ultrasonography in the localization and resection of insulinomas.
C. K. Brown (1997)
Thyroid nodules in the follow-up of irradiated individuals: comparison of thyroid ultrasound with scanning and palpation.
A. Schneider (1997)
Radiotherapy for pituitary adenoma: long-term outcome and sequelae.
M. W. McCord (1997)
Comparison of the Ligand Binding Specificity and Transcript Tissue Distribution of Estrogen Receptors α and β.
G. Kuiper (1997)
The Postmenopausal Estrogen/Progestin Interventions Study: primary outcomes in adherent women.
E. Barrett-Connor (1997)
Tumor-specific expression of alternatively spliced estrogen receptor messenger ribonucleic acid variants in human pituitary adenomas.
S. Chaidarun (1997)
Nodular thyroid disease in children and adolescents.
B. Millman (1997)
Differentiated thyroid carcinoma.
J. Hershman (1997)
Effects of Differing Antecedent Hypoglycemia on Subsequent Counterregulation in Normal Humans
S. Davis (1997)
Carcinoma of the Thyroid in Children - A Review
R. Feinmesser (1997)
Differentiated and medullary thyroid cancer in childhood and adolescence.
L. Mp (1997)
Pathophysiology of hyponatremia after transsphenoidal pituitary surgery.
B. Olson (1997)
Differentiated and medullary thyroid cancer in childhood and adolescence.
M. La Quaglia (1997)
Heterotopic autotransplantation of parathyroid tissue in children undergoing total thyroidectomy.
M. Skinner (1997)
Why some cases of retinopathy worsen when diabetic control improves
E. Chantelau (1997)
The Role of Hormone Replacement Therapy in the Risk for Breast Cancer and Total Mortality in Women with a Family History of Breast Cancer
T. Sellers (1997)
Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome
D. Liaw (1997)
Physical exercise and vasomotor symptoms in postmenopausal women.
T. Ivarsson (1998)
Stereotactic radiosurgery for recurrent surgically treated acromegaly: comparison with fractionated radiotherapy.
A. Landolt (1998)
Recent results of secondary transnasal surgery for residual or recurring acromegaly.
T. Abe (1998)
Effects of autonomic neuropathy on counterregulation and awareness of hypoglycemia in type 1 diabetic patients.
C. Meyer (1998)
Decreased epinephrine responses to hypoglycemia during sleep.
T. Jones (1998)
Consensus for the use of fibrates in the treatment of dyslipoproteinemia and coronary heart disease. Fibrate Consensus Group.
J. Fruchart (1998)
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
R. Turner (1998)
Multiple endocrine neoplasia--syndromes of the twentieth century.
R. Thakker (1998)
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.
R. Turner (1998)
Risk factors of severe hypoglycaemia in adult patients with Type I diabetes – a prospective population based study
I. Mühlhauser (1998)
Mortality and Cancer Incidence in Acromegaly: A Retrospective Cohort Study
S. Orme (1998)
Reversibility of joint thickening in acromegalic patients: an ultrasonography study.
A. Colao (1998)
Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey.
D. Eisenberg (1998)
Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly.
P. Freda (1998)
Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry.
D. Cooper (1998)
ACSM's Resource Manual for Guidelines for Exercise Testing and Prescription
J. Roitman (1998)
Long-term changes in nodular goiter: a 5-year prospective randomized trial of levothyroxine suppressive therapy for benign cold thyroid nodules.
E. Papini (1998)
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.
R. Turner (1998)
United Kingdom Prospective Diabetes Study 24: A 6-Year, Randomized, Controlled Trial Comparing Sulfonylurea, Insulin, and Metformin Therapy in Patients with Newly Diagnosed Type 2 Diabetes That Could Not Be Controlled with Diet Therapy
A. Wright (1998)
Cabergoline in the treatment of acromegaly: a study in 64 patients.
R. Abs (1998)
Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma.
C. Spencer (1998)
Why patients use alternative medicine: results of a national study.
J. Astin (1998)
Clinical features associated with metastasis and recurrence of differentiated thyroid cancer in children, adolescents and young adults
C. Welch Dinauer (1998)
Differentiated thyroid cancer: determinants of disease progression in patients <21 years of age at diagnosis: a report from the Surgical Discipline Committee of the Children's Cancer Group.
K. Newman (1998)
Pregnancy in acromegaly: successful therapeutic outcome.
V. Herman-Bonert (1998)
Long-term endocrinological follow-up evaluation in 115 patients who underwent transsphenoidal surgery for acromegaly.
P. Freda (1998)
Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly.
B. Swearingen (1998)
Thyroxine Suppressive Therapy in Patients with Nodular Thyroid Disease
H. Gharib (1998)
Differential changes in free and total insulin-like growth factor I after major, elective abdominal surgery: the possible role of insulin-like growth factor-binding protein-3 proteolysis.
C. Skjaerbaek (1998)
J. Luton (1998)
Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.
S. Haffner (1998)
Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.
J. Downs (1998)
Pulmonary metastases in children and adolescents with well-differentiated thyroid cancer.
A. Samuel (1998)
Prospective evaluation of vitamin E for hot flashes in breast cancer survivors.
D. Barton (1998)
Preoperative staging of thyroid papillary carcinoma with ultrasonography.
K. Shimamoto (1998)
Differentiated thyroid cancer in children and adolescents: Clinical outcome and mortality after long‐term follow‐up
R. Vassilopoulou-sellin (1998)
NEW APPROACHES TO THE DEVELOPMENT AND USE OF TREATMENT GUIDELINES
N. Johnson (1998)
Clinical features associated with metastasis and recurrence of differentiated thyroid cancer in children, adolescents and young adults. Clinical endocrinology 49:619628
CA Welch Dinauer (1998)
Differentiated thyroid cancer in children and adolescents: clinical outcome and mortality after long-term followup
R Vassilopoulou-Sellin (1998)
Suppression of Growth Hormone by Oral Glucose in the Evaluation of Tall Stature
R. Holl (1999)
Noninsulinoma pancreatogenous hypoglycemia: a novel syndrome of hyperinsulinemic hypoglycemia in adults independent of mutations in Kir6.2 and SUR1 genes.
F. J. Service (1999)
Comparison of Bedtime Insulin Regimens in Patients with Type 2 Diabetes Mellitus
Hannele Yki-Jrvinen (1999)
Menstrual irregularity in women with acromegaly.
G. Kaltsas (1999)
Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico.
R. Marchioli (1999)
Reduced thermoregulatory null zone in postmenopausal women with hot flashes.
R. Freedman (1999)
Impact of patient's age and disease duration on cardiac performance in acromegaly: a radionuclide angiography study.
A. Colao (1999)
Multiple endocrine neoplasia type 1.
A. A. Pannett (1999)
Regression of acromegalic left ventricular hypertrophy after lanreotide (a slow-release somatostatin analog).
J. Hradec (1999)
Microsatellite instability and loss of heterozygosity in radiation-associated thyroid carcinomas of Belarussian children and adults.
H. Richter (1999)
The incidence of cerebrovascular accidents in patients with pituitary adenoma.
M. Brada (1999)
IGF-II enhances trichostatin A-induced TGFbeta1 and p21(Waf1,Cip1, sdi1) expression in Hep3B cells.
S. Gray (1999)
Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group.
H. Rubins (1999)
Hypoglycemia due to an insulin-secreting small-cell carcinoma of the cervix.
M. Seckl (1999)
Pituitary Gigantism Causing Diabetic Ketoacidosis
N. Alvi (1999)
Growth hormone-secreting pituitary adenomas in childhood and adolescence: features and results of transnasal surgery.
T. Abe (1999)
Hot flushes and other menopausal symptoms in relation to soy product intake in Japanese women.
C. Nagata (1999)
Clinical and morphological features of undifferentiated monomorphous GH/TSH-secreting pituitary adenoma.
T. Škorić (1999)
Transdermal progesterone cream for vasomotor symptoms and postmenopausal bone loss.
H. B. Leonetti (1999)
Preliminary comparison of the endoscopic transnasal vs the sublabial transseptal approach for clinically nonfunctioning pituitary macroadenomas.
M. Sheehan (1999)
Low-potency oestrogen and risk of endometrial cancer: a case-control study
E. Weiderpass (1999)
Nutritional status, insulin-like growth factor-1 and quality of life in elderly women with hip fractures.
S. Ponzer (1999)
Cardiac effects of slow-release lanreotide, a slow-release somatostatin analog, in acromegalic patients.
R. Baldelli (1999)
Serum-free insulin-like growth factor I correlates with clearance in patients with chronic renal failure.
J. Frystyk (1999)
MRI of growth hormone-secreting pituitary adenomas: factors determining pretreatment hormone levels
N. Saeki (1999)
The British Diabetic Association Cohort Study, I: all‐cause mortality in patients with insulin‐treated diabetes mellitus
S. Laing (1999)
Post fine-needle aspiration histologic alterations of thyroid revisited.
Z. Baloch (1999)
Lithium as a potential adjuvant to 131I therapy of metastatic, well differentiated thyroid carcinoma.
S. Koong (1999)
Is the UICC/AJCC classification of primary tumor in childhood thyroid carcinoma valid?
J. Farahati (1999)
Human somatostatin receptor subtypes in acromegaly: distinct patterns of messenger ribonucleic acid expression and hormone suppression identify different tumoral phenotypes.
P. Jaquet (2000)
Differentiated thyroid cancer: clinical characteristics, treatment, and outcome in patients under 21 years of age who present with distant metastases. A report from the Surgical Discipline Committee of the Children's Cancer Group.
M. La Quaglia (2000)
The prolonged fast.
F. J. Service (2000)
Outcome of radiotherapy for acromegaly using normalization of insulin-like growth factor I to define cure.
J. Powell (2000)
Goldmann perimetry in acromegaly: a survey of 307 cases from 1951 through 1996.
O. Rivoal (2000)
Octreotide may act as a radioprotective agent in acromegaly.
A. Landolt (2000)
Interindividual Variation in Metabolism of Soy Isoflavones and Lignans: Influence of Habitual Diet on Equol Production by the Gut Microflora
I. Rowland (2000)
Long-term follow-up results of postoperative radiotherapy in 36 patients with acromegaly.
N. Biermasz (2000)
Age- and sex-adjusted iodine/creatinine ratio. A new standard in epidemiological surveys? Evaluation of three different estimates of iodine excretion based on casual urine samples and comparison to 24 h values
N. Knudsen (2000)
The reliability and validity of the impact on lifestyle questionnaire in patients with acromegaly.
W. Lenderking (2000)
Management of thyroid cancer: radioiodine ablation, "stunning," and treatment of thyroglobulin-positive, (131)I scan-negative patients.
J. Hurley (2000)
The RAS oncogene induces genomic instability in thyroid PCCL3 cells via the MAPK pathway
H. Saavedra (2000)
Transcranial-transdural real-time ultrasonography during transsphenoidal resection of a large pituitary tumor. Case report.
J. Atkinson (2000)
Noninsulinoma pancreatogenous hypoglycemia syndrome: an update in 10 surgically treated patients.
G. Thompson (2000)
Pituitary tumor registry: a novel clinical resource.
M. R. Drange (2000)
Age is the major determinant of recurrence in pediatric differentiated thyroid carcinoma.
A. Alessandri (2000)
RESPONSE: re: effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin
Hormonal and metabolic effects of radiotherapy in acromegaly: long-term results in 128 patients followed in a single center.
G. Barrande (2000)
Vasomotor Symptom Relief by Soy Isoflavone Extract Tablets in Postmenopausal Women: A Multicenter, Double‐Blind, Randomized, Placebo‐Controlled Study
D. Upmalis (2000)
Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant.
P. E. J. T. Rainer (2000)
Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40-55 years of age.
E. Gold (2000)
Postoperative radiotherapy in acromegaly is effective in reducing GH concentration to safe levels
N. Biermasz (2000)
Insular thyroid carcinoma in adolescents.
C. Lo (2000)
Criteria for cure of acromegaly: a consensus statement.
A. Giustina (2000)
Clinical and reimbursement issues in growth hormone use in adults.
B. Biller (2000)
Equal induction and persistence of chromosome aberrations involving chromosomes 1, 4 and 10 in thyroid cancer patients treated with radioactive iodine.
S. Puerto (2000)
Abnormalities of the thyroid in survivors of Hodgkin's disease: data from the Childhood Cancer Survivor Study.
C. Sklar (2000)
Oral Clonidine in Postmenopausal Patients with Breast Cancer Experiencing Tamoxifen-Induced Hot Flashes: A University of Rochester Cancer Center Community Clinical Oncology Program Study
K. Pandya (2000)
Thyroid cancer in children: the Royal Marsden Hospital experience.
D. Landau (2000)
Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: A North Central Cancer Treatment Group Trial.
S. Quella (2000)
Nestorone®: a progestin with a unique pharmacological profile
N. Kumar (2000)
Papillary thyroid cancer with pulmonary metastases in children: long-term prognosis.
J. Brink (2000)
The ret/PTC mutations are common in sporadic papillary thyroid carcinoma of children and young adults.
C. Fenton (2000)
Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study
A. Adler (2000)
Multiple-dose efficacy and safety of an extended-release form of niacin in the management of hyperlipidemia.
A. Goldberg (2000)
Impact of Diabetes on Long-Term Prognosis in Patients With Unstable Angina and Non–Q-Wave Myocardial Infarction: Results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) Registry
Klas Malmberg (2000)
Anaesthetic complications of acromegaly.
P. Seidman (2000)
The prevalence and characteristics of colorectal neoplasia in acromegaly.
A. Renehan (2000)
Is familial non-medullary thyroid carcinoma more aggressive than sporadic thyroid cancer? A multicenter series.
O. Alsanea (2000)
Multivariate analysis of prognostic factors for differentiated thyroid carcinoma in children
B. Jarzab (2000)
Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial
C. Loprinzi (2000)
A Prospective, Observational Study of Postmenopausal Hormone Therapy and Primary Prevention of Cardiovascular Disease
F. Grodstein (2000)
Hot flashes in the late reproductive years: risk factors for Africa American and Caucasian women.
E. Freeman (2001)
Longitudinal assessment of economic burden and clinical outcomes in acromegaly.
L. Wilson (2001)
Association between premature mortality and hypopituitarism
J. Tomlinson (2001)
Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease.
B. G. Brown (2001)
Differentiated thyroid carcinoma: a polygenic disease.
T. Links (2001)
Clinical features of differentiated thyroid carcinoma in children and adolescents from a sub-Himalayan iodine-deficient endemic zone
C. Bal (2001)
Effects of Diet and Sodium Intake on Blood Pressure: Subgroup Analysis of the DASH-Sodium Trial
W. Vollmer (2001)
Long-term follow-up of patients with initially benign thyroid fine-needle aspirations.
Y. Liel (2001)
CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2
M. Brandi (2001)
Metastatic Differentiated Thyroid Carcinoma: ClinicopathologicalProfile and Outcome in an Iodine Deficient Area
Anjali Mishra (2001)
Transsphenoidal surgery and adjuvant gamma knife treatment for growth hormone-secreting pituitary adenoma.
H. Ikeda (2001)
Risk factors for glucose intolerance in active acromegaly.
A. Kréze (2001)
Adult-onset nesidioblastosis causing hypoglycemia: an important clinical entity and continuing treatment dilemma.
R. Witteles (2001)
A clinicopathologic study of minimally invasive follicular carcinoma of the thyroid gland with a review of the English literature
L. Thompson (2001)
Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults.
P. Marzullo (2001)
Is the acromegalic cardiomyopathy reversible? Effect of 5-year normalization of growth hormone and insulin-like growth factor I levels on cardiac performance.
A. Colao (2001)
Risk factors for frequent and severe hypoglycemia in type 1 diabetes.
C. Allen (2001)
RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults.
R. Elisei (2001)
Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria.
J. Kreutzer (2001)
AACE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma. American Association of Clinical Endocrinologists. American College of Endocrinology.
R. Cobin (2001)
Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer.
J. Jacobson (2001)
Somatostatin receptor-specific analogs: effects on cell proliferation and growth hormone secretion in human somatotroph tumors.
D. Danila (2001)
Fractionated stereotactically guided radiotherapy and radiosurgery in the treatment of functional and nonfunctional adenomas of the pituitary gland.
S. Milker-Zabel (2001)
Resistance of [18f]-fluorodeoxyglucose-avid metastatic thyroid cancer lesions to treatment with high-dose radioactive iodine.
W. Wang (2001)
Postmenopausal Hormone Use and Secondary Prevention of Coronary Events in the Nurses' Health Study: A Prospective, Observational Study
F. Grodstein (2001)
Hormone replacement therapy and cognition: systematic review and meta-analysis.
E. LeBlanc (2001)
Conventional pituitary irradiation is effective in normalising plasma IGF-I in patients with acromegaly.
B. Gutt (2001)
Intensive insulin therapy in critically ill patients.
G. Van den Berghe (2001)
Hormone Replacement Therapy and Breast Cancer: A Qualitative Review
Trudy L. Bush (2001)
Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet
F. Sacks (2001)
Randomized Prospective Evaluation of Frozen-Section Analysis for Follicular Neoplasms of the Thyroid
Robert Udelsman (2001)
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist
A. J. Lely (2001)
Effects of preoperative octreotide treatment on different subtypes of 90 GH-secreting pituitary adenomas and outcome in one surgical centre.
T. Abe (2001)
Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes. The MIRACL study.
G. Schwartz (2001)
Evaluation of surgery for acromegaly: role of intraoperative growth hormone measurement?
S. Valdemarsson (2001)
Failure of radiotherapy in acromegaly.
R. Cozzi (2001)
Accuracy of fine needle aspiration biopsy of thyroid nodules in detecting malignancy in childhood: comparison with conventional clinical, laboratory, and imaging approaches.
A. Corrias (2001)
Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).
S. Grundy (2001)
Endoscopic Transnasal Pituitary Surgery: Report on 180 Cases
Shawn S. Nasseri (2001)
Thyroid Carcinoma Task Force 2001 AACE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma
RH Cobin (2001)
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Commentary
S. Yusuf (2002)
Dietary supplement use among menopausal women attending a San Francisco health conference
I. W. Kam (2002)
Surgical complications associated with the endoscopic endonasal transsphenoidal approach for pituitary adenomas.
P. Cappabianca (2002)
Understanding the treatment preferences of seriously ill patients.
T. Fried (2002)
Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial.
S. Grundy (2002)
Nasolacrimal drainage system obstruction from radioactive iodine therapy for thyroid carcinoma.
R. Kloos (2002)
Acid-labile subunit in growth hormone excess and deficiency in adults: evaluation of its diagnostic value in comparison with insulin-like growth factor (IGF)-I and IGF-binding protein-3.
I. Fukuda (2002)
Clinical Course of the Syndrome of Autoantibodies to the Insulin Receptor (Type B Insulin Resistance): A 28-Year Perspective
E. Arioglu (2002)
Prognosis for fertility and ovarian function after treatment with radioiodine for thyroid cancer
L. Vini (2002)
Hot Nodules in Children and Adolescents in Western Poland from 1996 to 2000: Clinical Analysis of 31 Patients
M. Niedziela (2002)
Differentiated thyroid cancer in children and adolescents
D. Giuffrida (2002)
Goals of statin therapy: Three viewpoints
G. Thompson (2002)
Pediatric surgical images: PET evaluation of papillary thyroid carcinoma recurrence.
S. Armstrong (2002)
Effects of two different somatostatin analogs on glucose tolerance in acromegaly
C. Ronchi (2002)
Treatment with Atorvastatin to the National Cholesterol Educational Program Goal Versus 'Usual' Care in Secondary Coronary Heart Disease Prevention
V. Athyros (2002)
Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).
D. Grady (2002)
Differentiated thyroid carcinomas with vascular invasion: a comparative study of follicular, Hürthle cell and papillary thyroid carcinoma
K. Mai (2002)
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial
J. Rossouw (2002)
Black cohosh and other herbal remedies associated with acute hepatitis
P. W. Whiting (2002)
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
C. Furberg (2002)
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies
Sarah Lewington (2002)
Well-differentiated thyroid carcinoma in Hong Kong Chinese patients under 21 years of age: a 35-year experience.
Y. Lee (2002)
Acromegaly—Consensus, What Consensus?
P. Trainer (2002)
Diagnosis and management of patients with thyroid nodules
W. Lawrence (2002)
Gender- and age-related differences in the endocrine parameters of acromegaly
A. Colao (2002)
Differentiated Thyroid Carcinoma That Express Sodium-Iodide Symporter Have a Lower Risk of Recurrence for Children and Adolescents
Aneeta Patel (2002)
The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery.
B. Meij (2002)
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.
W. Knowler (2002)
The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones.
K. Setchell (2002)
Current controversies in the management of pediatric patients with well-differentiated nonmedullary thyroid cancer: a review.
W. Hung (2002)
Maternal hypoglycemia during pregnancy in type 1 diabetes: maternal and fetal consequences
E. T. ter Braak (2002)
Prevalence, expenditures, and complications of multiple chronic conditions in the elderly.
J. Wolff (2002)
Childhood and adolescent thyroid carcinoma
P. Grigsby (2002)
Is the serum thyroglobulin response to recombinant human thyrotropin sufficient, by itself, to monitor for residual thyroid carcinoma?
R. Robbins (2002)
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial
J. Shepherd (2002)
Management of papillary and follicular (differentiated) thyroid cancer: new paradigms using recombinant human thyrotropin.
E. Mazzaferri (2002)
Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies
J. Evans (2002)
Risk indicators predictive for severe hypoglycemia during the first trimester of type 1 diabetic pregnancy.
I. Evers (2002)
Effect of Soy Phytoestrogens on Hot Flashes in Postmenopausal Women With Breast Cancer: A Randomized, Controlled Clinical Trial
C. Patten (2002)
Unexpected Hypoglycemia in a Critically Ill Patient
D. Bates (2002)
Acromegaly with apparently normal GH secretion: implications for diagnosis and follow-up.
E. Dimaraki (2002)
Genomic and nongenomic effects of estrogen in the vasculature.
M. Mendelsohn (2002)
Effects of thyroid-stimulating hormone suppression with levothyroxine in reducing the volume of solitary thyroid nodules and improving extranodular nonpalpable changes: a randomized, double-blind, placebo-controlled trial by the French Thyroid Research Group.
J. Wemeau (2002)
Testicular dose and fertility in men following I131 therapy for thyroid cancer
S. Hyer (2002)
Does radioiodine therapy have disadvantageous effects in non‐iodine accumulating differentiated thyroid carcinoma?
J. Schaap (2002)
Intramuscular depot medroxyprogesterone versus oral megestrol for the control of postmenopausal hot flashes in breast cancer patients: a randomized study.
G. Bertelli (2002)
Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial.
P. Serruys (2002)
Hypoglycemia-associated autonomic failure in advanced type 2 diabetes.
S. A. Segel (2002)
Insulin-Like Growth Factors and Insulin-Like Growth Factor Binding Proteins in Adult Patients with Severe Liver Disease before and after Orthotopic Liver Transplantation
M. Weber (2002)
Clinical significance of elevated level of serum antithyroglobulin antibody in patients with differentiated thyroid cancer after thyroid ablation
J. Chung (2002)
Hypoglycaemia: The limiting factor in the glycaemic management of Type I and Type II Diabetes*
P. Cryer (2002)
Diagnostic 131-iodine whole-body scan may be avoided in thyroid cancer patients who have undetectable stimulated serum Tg levels after initial treatment.
F. Pacini (2002)
Serum concentrations of sex hormone binding globulin are elevated in kwashiorkor and anorexia nervosa but not in marasmus.
Nathalie Pascal (2002)
Hot nodules in children and adolescents in western Poland 750 FRANCIS ET AL. from 1996 to 2000: clinical analysis of 31 patients
M Niedziela (2002)
Diagnostic 131-iodine whole-body scan may be avoided in thyroid cancer patients who have Page 67 of 95 T hy ro id D ow nl oa de d fr om o nl in e. lie be rt pu b. co m b y 80
F Pacini (2002)
Metastatic differentiated thyroid carcinoma: clinicopathological profile and outcome in an iodine deficient area. World journal of surgery 26:153-157
A Mishra (2002)
Does radioiodine therapy have disadvantageous effects in noniodine accumulating differentiated thyroid carcinoma? Clinical endocrinology 57:117124
J Schaap (2002)
Current controversies in the management of pediatric patients with well - differentiated non - medullary
W Hung (2002)
Serum Insulin-Like Growth Factor I Reference Values for an Automated Chemiluminescence Immunoassay System: Results from a Multicenter Study
G. Brabant (2003)
Treatment of Recurrent Papillary Thyroid Carcinoma in Children and Adolescents
P. Powers (2003)
Thyroid Carcinoma in the McCune-Albright Syndrome: Contributory Role of Activating Gsα Mutations
M. Collins (2003)
Control of follicle-stimulating hormone by estradiol and the inhibins: critical role of estradiol at the hypothalamus during the luteal-follicular transition.
C. Welt (2003)
Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: a population-based study of health service resource use.
G. Leese (2003)
Disappearance of Humoral Thyroid Autoimmunity after Complete Removal of Thyroid Antigens
L. Chiovato (2003)
Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial.
M. Steffes (2003)
Role of neck ultrasonography in the follow-up of children operated on for thyroid papillary cancer.
A. Antonelli (2003)
Risks of estrogen plus progestin therapy: a sensitivity analysis of findings in the Women's Health Initiative randomized controlled trial
S. Shapiro (2003)
Greater local recurrence occurs with "berry picking" than neck dissection in thyroid cancer.
Michael J. Musacchio (2003)
Differentiated thyroid cancer
Ajay Kumar (2003)
Second primary malignancies in thyroid cancer patients
C. Rubino (2003)
Effects of eicosapentaenoic acid on cardiovascular events in Japanese patients with hypercholesterolemia: rationale, design, and baseline characteristics of the Japan EPA Lipid Intervention Study (JELIS).
M. Yokoyama (2003)
Postmenopausal hormone therapy and change in mammographic density.
G. Greendale (2003)
Hypoglycemia in diabetes.
P. Cryer (2003)
Non-genomic actions of sex steroid hormones.
T. Simoncini (2003)
Ultralow-dose micronized 17beta-estradiol and bone density and bone metabolism in older women: a randomized controlled trial.
K. Prestwood (2003)
Gamma-knife radiosurgery in acromegaly: a 4-year follow-up study.
R. Attanasio (2003)
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial
J. McMurray (2003)
Insulin-like growth factor I correlates with lean body mass in cystic fibrosis patients
I. Sermet‐Gaudelus (2003)
Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden
H. Olsson (2003)
Clinical characterisation of severe hypoglycaemia--a prospective population-based study.
A. Holstein (2003)
Insulin sensitivity and glucose tolerance improve in patients with acromegaly converted from depot octreotide to pegvisomant.
W. Drake (2003)
Transsphenoidal surgery for pituitary tumors in the United States, 1996-2000: mortality, morbidity, and the effects of hospital and surgeon volume.
F. Barker (2003)
Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial.
V. Stearns (2003)
Insular carcinoma of the thyroid in an adolescent: a case report and review of the literature.
K. Yusuf (2003)
Long-term survival rates in young patients with thyroid carcinoma.
L. Kowalski (2003)
Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review.
D. Dewitt (2003)
Sleep-related hypoglycemia-associated autonomic failure in type 1 diabetes: reduced awakening from sleep during hypoglycemia.
S. Banarer (2003)
Twelve months of treatment with octreotide-LAR reduces joint thickness in acromegaly.
A. Colao (2003)
Recombinant human thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma.
F. Pacini (2003)
Influence of Estrogen Plus Progestin on Breast Cancer and Mammography in Healthy Postmenopausal Women: The Women's Health Initiative Randomized Trial
R. Chlebowski (2003)
MPA and postmenopausal coronary artery atherosclerosis revisited
T. Clarkson (2003)
Relationship between long durations and different regimens of hormone therapy and risk of breast cancer.
Christopher I. Li (2003)
The incidence of retinopathy 10 years after diagnosis in young adult people with diabetes: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS).
M. Henricsson (2003)
Hypoglycaemia in insulin‐treated Type 2 diabetes: frequency, symptoms and impaired awareness
J. Henderson (2003)
Mechanisms of abnormal cardiac repolarization during insulin-induced hypoglycemia.
R. Robinson (2003)
Effects of low‐iodide diet on postsurgical radioiodide ablation therapy in patients with differentiated thyroid carcinoma
Maurice J H M Pluijmen (2003)
Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment
A. Sniderman (2003)
Positive predictive value of serum thyroglobulin levels, measured during the first year of follow-up after thyroid hormone withdrawal, in thyroid cancer patients.
E. Baudin (2003)
Serum levels of insulin-like growth factor I and its binding proteins in health and disease.
A. Juul (2003)
High prevalence of cardiac valve disease in acromegaly: an observational, analytical, case-control study.
A. Colao (2003)
A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma.
E. Mazzaferri (2003)
Menopause after breast cancer: a survey on breast cancer survivors.
N. Biglia (2003)
Reversal of acromegalic cardiomyopathy in young but not in middle‐aged patients after 12 months of treatment with the depot long‐acting somatostatin analogue octreotide
A. Colao (2003)
Pituitary tumors and pregnancy.
M. Molitch (2003)
Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma
A. Frasoldati (2003)
Optimizing control of acromegaly: integrating a growth hormone receptor antagonist into the treatment algorithm.
D. Clemmons (2003)
Tumor Size and Extent of Disease at Diagnosis Predict the Response to Initial Therapy for Papillary Thyroid Carcinoma in Children and Adolescents
P. Powers (2003)
Assessment of long-term remission of acromegaly following surgery.
M. Krieger (2003)
Functioning pulmonary metastases of thyroid cancer: does radioiodine influence the prognosis?
E. Hindié (2003)
American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003.
S. Hodgson (2003)
Cancer incidence in adolescents and young adults in the United States, 1992-1997.
Xiao-Cheng Wu (2003)
Nesidioblastosis in adults: a challenging cause of organic hyperinsulinism
K. Kaczirek (2003)
The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients.
M. Riddle (2003)
An unusual cause of hyperinsulinaemic hypoglycaemia syndrome
P. Manning (2003)
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.
A. Chobanian (2003)
Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer.
M. Kouvaraki (2003)
Transdermal progesterone and its effect on vasomotor symptoms, blood lipid levels, bone metabolic markers, moods, and quality of life for postmenopausal women.
B. Wren (2003)
Three-hour spontaneous GH secretion profile is as reliable as oral glucose tolerance test for the diagnosis of acromegaly
S. Grottoli (2003)
The Cimicifuga preparation BNO 1055 vs. conjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers.
W. Wuttke (2003)
Imaging of neuroendocrine tumors: accuracy of helical CT versus SRS
B. Kumbasar (2003)
GUIDELINES FOR PEDIATRIC THYROID NODULES AND CANCER 745 D ow nl oa de d by
C Rubino (2003)
Recombinant human thyrotropinstimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma
F Pacini (2003)
Longterm survival rates in young patients with thyroid carcinoma. Archives of otolaryngology--head & neck surgery 129:746-749
LP Kowalski (2003)
GUIDELINES FOR PEDIATRIC THYROID NODULES AND CANCER
C Rubino (2003)
ATA GUIDELINES FOR PEDIATRIC THYROID NODULES AND CANCER
C Rubino (2003)
Effects of octreotide on sleep apnoea and tongue volume (magnetic resonance imaging) in patients with acromegaly.
B. Herrmann (2004)
Endoscopic ultrasound and neuroendocrine tumours of the pancreas.
A. Fritscher-ravens (2004)
Pituitary volume and headache: size is not everything.
M. Levy (2004)
Stereotactic conformal radiotherapy in patients with growth hormone-secreting pituitary adenoma.
S. Milker-Zabel (2004)
Clinical, hormonal and magnetic resonance imaging (MRI) predictors of transsphenoidal surgery outcome in acromegaly.
A. Bourdelot (2004)
Cardiovascular Complications in Acromegaly: Methods of Assessment
G. Vitale (2004)
Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly.
J. Ayuk (2004)
Application of three-tesla magnetic resonance imaging for diagnosis and surgery of sellar lesions.
S. Wolfsberger (2004)
A novel syndrome of autosomal-dominant hyperinsulinemic hypoglycemia linked to a mutation in the human insulin receptor gene.
K. Højlund (2004)
Pregnancy after high therapeutic doses of iodine-131 in differentiated thyroid cancer: potential risks and recommendations
D. Casara (2004)
Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial.
J. D. de Lemos (2004)
Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
S. Grundy (2004)
Serum levels of growth hormone-binding protein and insulin-like growth factor I in children and adolescents with Type 1 (insulin-dependent) diabetes mellitus
G. Massa (2004)
Differentiated thyroid carcinoma in childhood and adolescence—clinical course and role of radioiodine
S. Chow (2004)
Decreased quality of life in patients with acromegaly despite long-term cure of growth hormone excess.
N. Biermasz (2004)
Bioidentical hormone therapy: a review
L. Boothby (2004)
The MACIS Score Predicts the Clinical Course of Papillary Thyroid Carcinoma in Children and Adolescents
P. Powers (2004)
Papillary thyroid cancer with chest metastases only detected using radioactive iodine.
Sheng-Fong Kuo (2004)
Age-dependent variation of follicular size and expression of iodine transporters in human thyroid tissue.
A. Faggiano (2004)
Endoscopic transsphenoidal surgery
H. Jho (2004)
Clinical implications of the differences between diagnostic 123I and post-therapy 131I scans
Jason B Cohen (2004)
Intrasellar aneurysm and a growth hormone-secreting pituitary macroadenoma. Case report.
B. Sade (2004)
Intensive versus moderate lipid lowering with statins after acute coronary syndromes.
C. Cannon (2004)
Influence of autonomic neuropathy on QTc interval lengthening during hypoglycemia in type 1 diabetes.
Stuart Lee (2004)
Radiosurgery for pituitary adenomas
M. Brada (2004)
Follicular-cell derived thyroid cancer in children.
S. Leboulleux (2004)
Clinical Importance of Obesity Versus the Metabolic Syndrome in Cardiovascular Risk in Women: A Report From the Women’s Ischemia Syndrome Evaluation (WISE) Study
K. Kip (2004)
Plasma metanephrine levels are decreased in type 1 diabetic patients with a severely impaired epinephrine response to hypoglycemia, indicating reduced adrenomedullary stores of epinephrine.
B. D. de Galan (2004)
A meta-analysis of alcohol consumption and the risk of 15 diseases.
G. Corrao (2004)
Pituitary magnetic resonance imaging is not required in the postoperative follow-up of acromegalic patients with long-term biochemical cure after transsphenoidal surgery.
E. Zirkzee (2004)
Impact of diabetes and previous myocardial infarction on long-term survival: 25-year mortality follow-up of primary screenees of the Multiple Risk Factor Intervention Trial.
O. Vaccaro (2004)
Self Image and Quality of Life in Acromegaly
P. Pantanetti (2004)
Surgeon-performed ultrasound in the management of thyroid malignancy.
C. Solórzano (2004)
Clinical outcomes in managed-care patients with coronary heart disease treated aggressively in lipid-lowering disease management clinics: the alliance study.
M. Koren (2004)
Confusion in Clinical Laboratory GH and IGF-I Reprots
S. Melmed (2004)
Pharmacokinetic and pharmacodynamic characteristics of a long-acting growth hormone (GH) preparation (nutropin depot) in GH-deficient children.
S. Kemp (2004)
Hormone replacement therapy and improved survival among postmenopausal women diagnosed with colon cancer (USA)
M. Slattery (2004)
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial
H. Colhoun (2004)
A meta-analysis of superior thyroid artery variations in different human groups and their clinical implications.
R. Toni (2004)
Systemic complications of acromegaly: epidemiology, pathogenesis, and management.
A. Colao (2004)
Acromegaly: historical perspectives and current therapy
J. Jane (2004)
Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies.
M. Hanefeld (2004)
Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66.
R. Stevens (2004)
A prospective study of thyroid nodular disease in children and adolescents in western Poland from 1996 to 2000 and the incidence of thyroid carcinoma relative to iodine deficiency and the Chernobyl disaster
M. Niedziela (2004)
Diagnostic value of serum thyroglobulin measurements in the follow‐up of differentiated thyroid carcinoma, a structured meta‐analysis
C. Eustatia-Rutten (2004)
Follow-up of low-risk patients with differentiated thyroid carcinoma: a European perspective.
M. Schlumberger (2004)
Influence of HRT on prognostic factors for breast cancer: a systematic review after the Women's Health Initiative trial.
C. Antoine (2004)
Is chest x-ray or high-resolution computed tomography scan of the chest sufficient investigation to detect pulmonary metastasis in pediatric differentiated thyroid cancer?
C. Bal (2004)
The diagnosis and medical management of advanced neuroendocrine tumors.
G. Kaltsas (2004)
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial.
G. Anderson (2004)
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994.
T. Pedersen (2004)
Current Strategies for Surgical Management and Adjuvant Treatment of Childhood Papillary Thyroid Carcinoma
G. Thompson (2004)
Pathology and genetics of tumours of endocrine organs
R. DeLellis (2004)
Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Espanol de Acromegalia, REA).
A. Mestrón (2004)
Detection of recurrent papillary thyroid carcinoma by thyroglobulin assessment in the needle washout after fine-needle aspiration of suspicious lymph nodes.
H. Baskin (2004)
Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women: a randomized controlled trial.
S. Kreijkamp-Kaspers (2004)
Selective arterial calcium stimulation and hepatic venous sampling in the evaluation of hyperinsulinemic hypoglycemia: potential and limitations.
P. Wiesli (2004)
Predictive Factors for Recurrence from a Series of 74 Children and Adolescents with Differentiated Thyroid Cancer
F. Borson-Chazot (2004)
Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycaemia, following institution of rational, intensive insulin therapy in IDDM
C. Fanelli (2004)
Factors influencing the basal and recombinant human thyrotropin-stimulated serum thyroglobulin in patients with metastatic thyroid carcinoma.
R. Robbins (2004)
Raloxifene decreases serum IGF-I in male patients with active acromegaly.
E. Dimaraki (2004)
Commonly used types of postmenopausal estrogen for treatment of hot flashes: scientific review.
H. Nelson (2004)
Influence of marketed herbal menopause preparations on MCF-7 cell proliferation
C. Bodinet (2004)
Severe hypoglycaemia in 1076 adult patients with type 1 diabetes: influence of risk markers and selection
U. Pedersen-Bjergaard (2004)
Hormone replacement therapy and cardiovascular disease: lessons from a monkey model of postmenopausal women.
J. Williams (2004)
Prolonged cardiac repolarisation during spontaneous nocturnal hypoglycaemia in children and adolescents with type 1 diabetes
N. Murphy (2004)
Grading quality of evidence and strength of recommendations
D. Atkins (2004)
Effect of a yearlong, moderate-intensity exercise intervention on the occurrence and severity of menopause symptoms in postmenopausal women
E. Aiello (2004)
Estrogen replacement therapy and risk of fatal breast cancer in a prospective cohort of postmenopausal women in the United States
D. B. Willis (2004)
Follicular thyroid carcinoma: Histology and prognosis
A. D'avanzo (2004)
Clinicopathologic significance of histologic vascular invasion in papillary and follicular thyroid carcinomas.
J. Furlan (2004)
Optimal low-density lipoprotein is 50 to 70 mg/dl: lower is better and physiologically normal.
J. O’Keefe (2004)
The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk
G. Walldius (2004)
Iodine-131 treatment and high-resolution CT: results in patients with lung metastases from differentiated thyroid carcinoma
S. Ilgan (2004)
Differentiated thyroid carcinoma in childhood and adolescence-clinical course and role of radioiodine. Pediatric blood & cancer
SM Chow (2004)
D ow nl oa de d fr om o nl in e. lie be rt pu b. co m b y 18 9
A Faggiano (2004)
Diagnostic value of serum thyroglobulin measurements in the follow-up of differentiated thyroid carcinoma, a structured meta-analysis. Clinical endocrinology 61:61-74
CF Eustatia-Rutten (2004)
Is chest x-ray or high-resolution computed tomography scan of the chest sufficient investigation to detect pulmonary metastasis in pediatric differentiated thyroid cancer? Thyroid 14:217–225
CS Bal (2004)
Age-dependent 746 FRANCIS ET AL. variation of follicular size and expression of iodine transporters in human thyroid tissue
A Faggiano (2004)
A rapid method for analyzing serum pro-insulin-like growth factor-II in patients with non-islet cell tumor hypoglycemia.
F. Miraki-Moud (2005)
Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery.
Geoffrey J Service (2005)
Persistent Hyperinsulinemic Hypoglycemia in 15 Adults With Diffuse Nesidioblastosis: Diagnostic Criteria, Incidence, and Characterization of β-Cell Changes
M. Anlauf (2005)
Gross total resection or debulking of pituitary adenomas improves hormonal control of acromegaly by somatostatin analogs.
P. Petrossians (2005)
Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review.
B. Jarzab (2005)
High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial.
T. Pedersen (2005)
Intensive lipid lowering with atorvastatin in patients with stable coronary disease.
J. Larosa (2005)
Psychosocial aspects of survivors of childhood cancer or leukemia.
L. Massimo (2005)
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial
J. Dormandy (2005)
Carpal tunnel syndrome and acromegaly
H. Baum (2005)
Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case-control study
S. Yusuf (2005)
Risk of tumorigenesis in overgrowth syndromes: A comprehensive review
P. Lapunzina (2005)
Breast cancer risk in relation to different types of hormone replacement therapy in the E3N‐EPIC cohort
A. Fournier (2005)
A single recombinant human thyrotropin-stimulated serum thyroglobulin measurement predicts differentiated thyroid carcinoma metastases three to five years later.
R. Kloos (2005)
The prognostic value of primary tumor size in papillary and follicular thyroid carcinoma
A. Machens (2005)
Follicular Cell-Derived Thyroid Cancer in Children
S. Leboulleux (2005)
Efficacy of Thyroid Hormone Suppression for Benign Thyroid Nodules: Meta-Analysis of Randomized Trials
M. Sdano (2005)
Frequency and predictors of hypoglycaemia in Type 1 and insulin‐treated Type 2 diabetes: a population‐based study
L. Donnelly (2005)
The implication of somatotroph adenoma phenotype to somatostatin analog responsiveness in acromegaly.
S. Bhayana (2005)
Conditional BRAFV600E expression induces DNA synthesis, apoptosis, dedifferentiation, and chromosomal instability in thyroid PCCL3 cells.
N. Mitsutake (2005)
Relationship between disease-related morbidity and biochemical markers of activity in patients with acromegaly.
J. Puder (2005)
Consensus statement: medical management of acromegaly.
S. Melmed (2005)
Massive insulin secretion in response to anaerobic exercise in exercise-induced hyperinsulinism.
T. Meissner (2005)
Insulin autoimmunity and hypoglycemia in seven white patients.
A. Basu (2005)
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.
D. Nathan (2005)
Loss of the decrement in intraislet insulin plausibly explains loss of the glucagon response to hypoglycemia in insulin-deficient diabetes: documentation of the intraislet insulin hypothesis in humans.
B. Raju (2005)
Benefits of niacin by glycemic status in patients with healed myocardial infarction (from the Coronary Drug Project).
P. Canner (2005)
Early nephropathy in type 1 diabetes: A new perspective on who will and who will not progress
B. Perkins (2005)
Reduced hypoglycemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes.
J. Rosenstock (2005)
Should diabetes be considered a coronary heart disease risk equivalent?: results from 25 years of follow-up in the Renfrew and Paisley survey.
Lucinda Whiteley (2005)
The acromegalic arthropathy.
A. Colao (2005)
Preference-Based Antithrombotic Therapy in Atrial Fibrillation: Implications for Clinical Decision Making
M. Man-Son-Hing (2005)
Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis.
C. Wanner (2005)
Cerebrospinal fluid leak and meningitis associated with nasal continuous positive airway pressure therapy.
T. Kuźniar (2005)
Thyroid fine‐needle aspiration biopsy in children and adolescents: Experience with 218 aspirates
M. Amrikachi (2005)
Sonography of Thyroid Nodules: A “Classic Pattern” Diagnostic Approach
C. Reading (2005)
Development and clinical impact of thyroglobulin antibodies in patients with differentiated thyroid carcinoma during the first 3 years after thyroidectomy.
R. Görges (2005)
Androgens and body composition in the aging male.
M. Doga (2005)
Beneficial Effects of a Dietary Approaches to Stop Hypertension Eating Plan on Features of the Metabolic Syndrome
L. Azadbakht (2005)
Outcome of gamma knife radiosurgery in 82 patients with acromegaly: correlation with initial hypersecretion.
F. Castinetti (2005)
Follicular Thyroid Carcinoma: The Role of Histology and Staging Systems in Predicting Survival
C. Lo (2005)
Commentary: imaging of islet-cell tumours.
A. Grossman (2005)
Factitious Hyperinsulinism Leading to Pancreatectomy: Severe Forms of Munchausen Syndrome by Proxy
I. Giurgea (2005)
Clinical review: The antitumoral effects of somatostatin analog therapy in acromegaly.
J. Bevan (2005)
Differentiated thyroid carcinoma in children and adolescents
J. Harness (2005)
Serum thyrotropin (TSH) levels after recombinant human TSH injections in children and teenagers with papillary thyroid cancer.
S. Iorcansky (2005)
Meta-analysis of the relationship between alcohol consumption and coronary heart disease and mortality in type 2 diabetic patients
L. Koppes (2005)
Predicting death in the nursing home: development and validation of the 6-month Minimum Data Set mortality risk index.
D. Porock (2005)
Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program.
W. Knowler (2005)
Thyroid-hormone therapy and thyroid cancer: a reassessment
B. Biondi (2005)
Cerebrospinal Fluid Leakage During Transsphenoidal Surgery: Postoperative External Lumbar Drainage Reduces the Risk for Meningitis
M. O. van Aken (2005)
Glycaemic control and severe hypoglycaemia following training in flexible, intensive insulin therapy to enable dietary freedom in people with type 1 diabetes: a prospective implementation study
A. Sämann (2005)
Hormone replacement therapy: pathobiological aspects of hormone-sensitive cancers in women relevant to epidemiological studies on HRT: a mini-review.
M. Dietel (2005)
Repeated fine-needle aspiration of the thyroid in benign nodular thyroid disease: critical evaluation of long-term follow-up.
A. Orlandi (2005)
Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia
M. Patti (2005)
The role of a more extensive surgical approach in the initial multimodality management of papillary thyroid cancer in children.
R. Savio (2005)
Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer?
K. Nakada (2005)
Mechanisms of hypoglycemia-associated autonomic failure and its component syndromes in diabetes.
P. Cryer (2005)
Relative efficacy of atorvastatin 80 mg and pravastatin 40 mg in achieving the dual goals of low-density lipoprotein cholesterol <70 mg/dl and C-reactive protein <2 mg/l: an analysis of the PROVE-IT TIMI-22 trial.
P. Ridker (2005)
A meta-analysis of inferior thyroid artery variations in different human ethnic groups and their clinical implications.
R. Toni (2005)
Colonoscopic screening and follow-up in patients with acromegaly: a multicenter study in Italy.
M. Terzolo (2005)
Children with differentiated thyroid cancer achieve adequate hyperthyrotropinemia within 14 days of levothyroxine withdrawal.
W. Kuijt (2005)
Hypoglycemia in stable, insulin-treated veterans with type 2 diabetes: a prospective study of 1662 episodes.
G. Murata (2005)
Long-acting somatostatin analog therapy of acromegaly: a meta-analysis.
P. Freda (2005)
Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia.
Workgroup on Hypoglycemia (2005)
A nationwide survey of mortality in acromegaly.
R. Kauppinen-Mäkelin (2005)
Coronary heart disease prevention and age inequalities: the first year of the National Service Framework for CHD.
J. Hippisley-Cox (2005)
Stereotactic Radiosurgery for Pituitary Adenomas: A Review of the Literature
E. Laws (2005)
Combined therapy with somatostatin analogues and weekly pegvisomant in active acromegaly
J. Feenstra (2005)
Islet Hyperplasia in Adults: Challenge to Preoperatively Diagnose Non-Insulinoma Pancreatogenic Hypoglycemia Syndrome
A. Starke (2005)
BRAF mutations are uncommon in papillary thyroid cancer of young patients.
Karen Penko (2005)
Mild to Moderate Muscular Symptoms with High-Dosage Statin Therapy in Hyperlipidemic Patients —The PRIMO Study
E. Bruckert (2005)
Endoscopic ultrasound in the localisation of pancreatic islet cell tumours.
A. McLean (2005)
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial
A. Keech (2005)
Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement.
M. Frates (2005)
Pegvisomant therapy in pituitary gigantism: successful treatment in a 12-year-old girl.
M. Rix (2005)
A critical analysis of pituitary tumor shrinkage during primary medical therapy in acromegaly.
S. Melmed (2005)
Clinically silent somatotropinomas may be biochemically active.
Alla A Sakharova (2005)
Diagnosis of thyroid cancer in children: value of gray-scale and power doppler US.
A. Lyshchik (2005)
Risk of second brain tumor after conservative surgery and radiotherapy for pituitary adenoma: update after an additional 10 years.
G. Minniti (2005)
Cabergoline Decreases Somatotroph Adenoma Size: A Case Report
M. Rickels (2005)
Acromegaly and the Cardiovascular System
G. Lombardi (2006)
Effect of Lowering LDL Cholesterol Substantially Below Currently Recommended Levels in Patients With Coronary Heart Disease and Diabetes
J. Shepherd (2006)
Hormone Therapy and Coronary Heart Disease: The Role of Time since Menopause and Age at Hormone Initiation
F. Grodstein (2006)
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.
S. Kahn (2006)
Hyperinsulinemic hypoglycemia after gastric bypass surgery is not accompanied by islet hyperplasia or increased beta-cell turnover.
J. Meier (2006)
Pathology and genetics of thyroid carcinoma
R. DeLellis (2006)
Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: metaanalysis of randomised controlled trials
J. Costa (2006)
Pathogenesis, diagnosis and management of thyroid nodules in children.
M. Niedziela (2006)
Effect of sex and assay method on serum concentrations of growth hormone in patients with acromegaly and in healthy controls.
H. Markkanen (2006)
The diagnostic value for differentiated thyroid carcinoma metastases of thyroglobulin (Tg) measurement in washout fluid from fine-needle aspiration biopsy of neck lymph nodes is maintained in the presence of circulating anti-Tg antibodies.
F. Boi (2006)
Iodine 131 thyroid ablation in female children and adolescents: Long-term risk of infertility and birth defects
M. Smith (2006)
Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal.
H. Hänscheid (2006)
Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy.
C. Cannon (2006)
Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F]fluoro-2-deoxy-D-glucose-positron emission tomography scanning.
R. Robbins (2006)
Frequency and risk factors of severe hypoglycaemia in insulin‐treated Type 2 diabetes: a cross‐sectional survey
K. Akram (2006)
GH deficiency in patients irradiated for acromegaly: significance of GH stimulatory tests in relation to the 24 h GH secretion.
A. A. van der Klaauw (2006)
Comparative evaluation of recombinant human thyrotropin-stimulated thyroglobulin levels, 131I whole-body scintigraphy, and neck ultrasonography in the follow-up of patients with papillary thyroid microcarcinoma who have not undergone radioiodine therapy.
M. Torlontano (2006)
Intensive insulin therapy in the medical ICU.
G. Van den Berghe (2006)
Effects of hormone therapy on brain morphology of healthy postmenopausal women: a Voxel-based morphometry study
M. Boccardi (2006)
Heterogeneity of low-density lipoprotein particle number in patients with type 2 diabetes mellitus and low-density lipoprotein cholesterol <100 mg/dl.
W. Cromwell (2006)
Intraoperative high-field magnetic resonance imaging in transsphenoidal surgery of hormonally inactive pituitary macroadenomas.
C. Nimsky (2006)
Thyroid Cancer in Children: Management and Outcome Experience of a Referral Center
A. Popovtzer (2006)
Thyroid Cancer in Childhood Cancer Survivors: A Detailed Evaluation of Radiation Dose Response and its Modifiers
C. Ronckers (2006)
Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial.
S. Garg (2006)
Brief report: Coronary heart disease events associated with hormone therapy in younger and older women
S. Salpeter (2006)
Presurgical treatment with somatostatin analogs in patients with acromegaly: effects on the remission and complication rates.
M. Losa (2006)
An Evidence-based Approach to Familial Nonmedullary Thyroid Cancer: Screening, Clinical Management, and Follow-up
R. Sippel (2006)
Reconsidering medication appropriateness for patients late in life.
H. Holmes (2006)
Biochemical evaluation of disease activity after pituitary surgery in acromegaly: a critical analysis of patients who spontaneously change disease status
A. Espinosa-de-los-Monteros (2006)
High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium.
A. Daly (2006)
Results of a randomised controlled cross-over trial on the effect of continuous subcutaneous glucose monitoring (CGMS) on glycaemic control in children and adolescents with type 1 diabetes.
D. Deiss (2006)
Effects of early statin treatment on symptomatic heart failure and ischemic events after acute myocardial infarction in Japanese.
T. Sakamoto (2006)
Hypoglycemia in Type 2 diabetic patients randomized to and maintained on monotherapy with diet, sulfonylurea, metformin, or insulin for 6 years from diagnosis: UKPDS73.
A. Wright (2006)
Nocturnal hypoglycemia in type 1 diabetes: an assessment of preventive bedtime treatments.
B. Raju (2006)
American Cancer Society Guidelines for the Early Detection of Cancer, 2006
R. Smith (2006)
Iodine-123 as a diagnostic imaging agent in differentiated thyroid carcinoma: a comparison with iodine-131 post-treatment scanning and serum thyroglobulin measurement
M. Urhan (2006)
High-dose atorvastatin after stroke or transient ischemic attack.
P. Amarenco (2006)
The influence of growth hormone status on physical impairments, functional limitations, and health-related quality of life in adults.
L. Woodhouse (2006)
Acute coronary syndromes and diabetes: Is intensive lipid lowering beneficial? Results of the PROVE IT-TIMI 22 trial.
S. Ahmed (2006)
Consensus statement on the standardisation of GH assays.
P. Trainer (2006)
Natural history of thyroid nodules in survivors of pediatric Hodgkin lymphoma
M. Metzger (2006)
Hyperinsulinemic hypoglycemia following gastric bypass surgery for obesity
A. Goldfine (2006)
On the prevalence of familial nonmedullary thyroid cancer in multiply affected kindreds.
N. D. Charkes (2006)
Comprehensive Clinical Assessment of 740 Cases of Surgically Treated Thyroid Cancer in Children of Belarus
Y. Demidchik (2006)
Testicular function after radioiodine therapy in patients with thyroid cancer.
P. Rosário (2006)
European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium.
F. Pacini (2006)
Value of preoperative ultrasonography in the surgical management of initial and reoperative papillary thyroid cancer.
J. Stulak (2006)
Potassium supplementation for the management of primary hypertension in adults.
H. Dickinson (2006)
Clinical features and morphological characterization of 10 patients with noninsulinoma pancreatogenous hypoglycaemia syndrome (NIPHS)
J. G. Won (2006)
American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules.
H. Gharib (2006)
Estrogen carcinogenesis in breast cancer.
J. Yager (2006)
Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial
H. Nakamura (2006)
Endocrine University: evolution of a novel educational program.
H. Gharib (2006)
Evidence-based Review of Treatment and Follow up of Pediatric Patients with Differentiated Thyroid Carcinoma
M. Rachmiel (2006)
Management of paediatric thyroid carcinoma: recent experience with recombinant human thyroid stimulating hormone in preparation for radioiodine therapy
W. Lau (2006)
Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty‐person/ten‐country panel
P. Barter (2006)
Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials.
C. Stettler (2006)
Mechanisms of sympathoadrenal failure and hypoglycemia in diabetes.
P. Cryer (2006)
Pregnancy in acromegaly: a one-center experience.
R. Cozzi (2006)
Predictors of tumor shrinkage after primary therapy with somatostatin analogs in acromegaly: a prospective study in 99 patients.
A. Colao (2006)
Continuous glucose monitoring and closed‐loop systems
R. Hovorka (2006)
Empiric radioactive iodine dosing regimens frequently exceed maximum tolerated activity levels in elderly patients with thyroid cancer.
R. M. Tuttle (2006)
Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer.
M. Sywak (2006)
Meglitinide analogues: a review of clinical data focused on recent trials.
J. Blicklé (2006)
Muscle damage induced by black cohosh (Cimicifuga racemosa).
P. Minciullo (2006)
Insulinomas may present with normoglycemia after prolonged fasting but glucose-stimulated hypoglycemia.
P. Kar (2006)
Lung toxicity in radioiodine therapy of thyroid carcinoma: development of a dose-rate method and dosimetric implications of the 80-mCi rule.
G. Sgouros (2006)
Feasibility of Automating Insulin Delivery for the Treatment of Type 1 Diabetes
G. Steil (2006)
AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute.
S. Smith (2006)
Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in ATA GUIDELINES FOR PEDIATRIC THYROID NODULES AND CANCER
M Sywak (2006)
Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in ATA GUIDELINES FOR PEDIATRIC THYROID NODULES AND CANCER 751 D ow nl oa de d by
M Sywak (2006)
Pathogenesis, diagnosis and management of thyroid nodules in children. Endocrine-related cancer
M Niedziela (2006)
Fluorine-18-L-dihydroxyphenylalanine (18F-DOPA) positron emission tomography as a tool to localize an insulinoma or beta-cell hyperplasia in adult patients.
S. Kauhanen (2007)
Thyroid cancer in childhood: management strategy, including dosimetry and long-term results.
M. Luster (2007)
Real-time continuous glucose monitoring
B. Buckingham (2007)
Radiotherapy and radiosurgery in acromegaly
F. Castinetti (2007)
Reduction in Weight and Cardiovascular Disease Risk Factors in Individuals With Type 2 Diabetes
X. Pi-Sunyer (2007)
Relating mean blood glucose and glucose variability to the risk of multiple episodes of hypoglycaemia in type 1 diabetes
E. Kilpatrick (2007)
Niacin in cardiovascular prevention: mechanisms, efficacy, and safety
J. Guyton (2007)
Total Thyroidectomy and Adjuvant Radioiodine Treatment Independently Decrease Locoregional Recurrence Risk in Childhood and Adolescent Differentiated Thyroid Cancer
D. Handkiewicz-Junak (2007)
Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis
M. Yokoyama (2007)
The decrease in breast-cancer incidence in 2003 in the United States.
P. Ravdin (2007)
Impact of preoperative ultrasonographic staging of the neck in papillary thyroid carcinoma.
Hernán E González (2007)
Defective Awakening Response to Nocturnal Hypoglycemia in Patients with Type 1 Diabetes Mellitus
B. Schultes (2007)
Factors related to the recurrence of thyroid nodules after surgery for benign radiation-related nodules.
Sathya Subbiah (2007)
Continuous glucose monitoring in children with type 1 diabetes.
B. Buckingham (2007)
Design and baseline characteristics of the simvastatin and ezetimibe in aortic stenosis (SEAS) study.
A. Rossebø (2007)
Colesevelam hydrochloride-ezetimibe combination lipid-lowering therapy in patients with diabetes or metabolic syndrome and a history of statin intolerance.
S. Rivers (2007)
Gamma knife stereotactic radiosurgery for acromegaly.
E. Vik-Mo (2007)
Operative strategy for follicular thyroid cancer in risk groups stratified by pTNM staging.
J. Lin (2007)
Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal.
A. Goldfine (2007)
Magnetic Resonance Imaging of Thyroid Cancer
Asako Miyakoshi (2007)
Impact of statin dosing intensity on transaminase and creatine kinase.
K. M. Dale (2007)
Dopamine agonists and the risk of cardiac-valve regurgitation.
R. Schade (2007)
Hypoglycemia due to paraneoplastic secretion of insulin-like growth factor-I.
W. Daughaday (2007)
Treatment with growth hormone receptor antagonist in acromegaly: effect on cardiac structure and performance.
R. Pivonello (2007)
The long-term cardiovascular outcome of different GH-lowering treatments in acromegaly
L. Marinis (2007)
Radioactive iodine therapy in poorly differentiated thyroid cancer
R. M. Tuttle (2007)
LDL Particle Number and Risk of Future Cardiovascular Disease in the Framingham Offspring Study - Implications for LDL Management.
W. Cromwell (2007)
Serum calcium slope predicts hypocalcaemia following thyroid surgery.
S. Walsh (2007)
Gamma Knife surgery for Cushing's disease.
J. Jagannathan (2007)
Monitoring thyroglobulin in a sensitive immunoassay has comparable sensitivity to recombinant human tsh-stimulated thyroglobulin in follow-up of thyroid cancer patients.
R. Smallridge (2007)
A 26-Week, Randomized, Parallel, Treat-to-Target Trial Comparing Insulin Detemir With NPH Insulin as Add-On Therapy to Oral Glucose-Lowering Drugs in Insulin-Naïve People With Type 2 Diabetes
L. Kennedy (2007)
Lung transplantation for pulmonary metastases and radiation-induced pulmonary fibrosis after radioactive iodine ablation of extensive lung metastases from papillary thyroid carcinoma.
James A. Lee (2007)
End-of-life decision making
K. Rosenfeld (2007)
Sulfonylurea Compounds Uncouple the Glucose Dependence of the Insulinotropic Effect of Glucagon-Like Peptide 1
J. de Heer (2007)
Adolescent overweight and future adult coronary heart disease.
K. Bibbins-Domingo (2007)
Glycemic Control and Type 2 Diabetes Mellitus: The Optimal Hemoglobin A1c Targets. A Guidance Statement from the American College of Physicians
A. Qaseem (2007)
Hypoglycemia due to an Insulin Binding Antibody in a Patient with an IgA-κ Myeloma
D. Halsall (2007)
The incidence of cancer and rate of false-negative cytology in thyroid nodules greater than or equal to 4 cm in size.
K. Mccoy (2007)
Clinical relevance of highly sensitive Tg assay in monitoring patients treated for differentiated thyroid cancer
A. Iervasi (2007)
Glycemic thresholds for activation of counterregulatory hormone and symptom responses in islet transplant recipients.
M. Rickels (2007)
18F-FDG PET/CT in patients with suspected recurrent or metastatic well-differentiated thyroid cancer.
A. Shammas (2007)
Is There a Place for Insulin Pump Therapy in Your Practice
J. Skyler (2007)
Mechanisms of Disease: molecular genetics of childhood thyroid cancers
S. Yamashita (2007)
Differentiated thyroid cancer in children and adults: same or distinct disease?
B. Jarzab (2007)
Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibe.
R. Temel (2007)
Safety considerations with niacin therapy.
J. Guyton (2007)
Thyroglobulin detection in fine-needle aspirates of cervical lymph nodes: a technique for the diagnosis of metastatic differentiated thyroid cancer.
N. Cunha (2007)
Incretin hypersecretion in post-gastric bypass hypoglycemia--primary problem or red herring?
A. Vella (2007)
Estrogen therapy and coronary-artery calcification.
J. Manson (2007)
Comparison of seven serum thyroglobulin assays in the follow-up of papillary and follicular thyroid cancer patients.
M. Schlumberger (2007)
A Systematic Review and Meta-Analysis of Hypoglycemia and Cardiovascular Events
A. Gangji (2007)
Maternal Glycemic Control and Hypoglycemia in Type 1 Diabetic Pregnancy
E. Mathiesen (2007)
Hypoglycemia due to paraneoplastic secretion of insulin-like growth factor-I in a patient with metastasizing large-cell carcinoma of the lung.
M. Nauck (2007)
Forty month follow-up of persistent and difficultly controlled acromegalic patients treated with depot long acting somatostatin analog octreotide.
D. Yetkin (2007)
Hereditary Non-medullary Thyroid Cancer
E. Kebebew (2007)
Childhood thyroid cancer in Belarus, Russia, and Ukraine after Chernobyl and at present.
Y. Demidchik (2007)
Neoplasia of the female reproductive tract
D. Archer (2007)
Impact of somatostatin analogs on the heart in acromegaly: a metaanalysis.
P. Maison (2007)
Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus.
K. Horvath (2007)
Hypoglycemic neuronal death is triggered by glucose reperfusion and activation of neuronal NADPH oxidase.
S. Suh (2007)
Applicability of Intraoperative Parathyroid Hormone Assay During Total Thyroidectomy as a Guide for the Surgeon to Selective Parathyroid Tissue Autotransplantation
M. Barczyński (2007)
Therapeutic impact of 18FDG-PET/CT in the management of iodine-negative recurrence of differentiated thyroid carcinoma.
E. Mirallié (2007)
Use of statins and risk of haematological malignancies: a meta-analysis of six randomized clinical trials and eight observational studies.
S. Bonovas (2007)
Insulin, C-peptide and proinsulin for the biochemical diagnosis of hypoglycaemia related to endogenous hyperinsulinism.
D. Vezzosi (2007)
Effect of transsphenoidal surgery on sleep apnoea in acromegaly.
L. Sze (2007)
Radiosurgery of growth hormone-producing pituitary adenomas: factors associated with biochemical remission.
B. Pollock (2007)
A phase II trial of doxorubicin and interferon alpha 2b in advanced, non-medullary thyroid cancer
A. Argiris (2007)
Ultrasound criteria of malignancy for cervical lymph nodes in patients followed up for differentiated thyroid cancer.
S. Leboulleux (2007)
Rosuvastatin in older patients with systolic heart failure.
J. Kjekshus (2007)
A review of human and analogue insulin trials.
S. Gough (2007)
Systematic Review: Comparative Effectiveness and Safety of Oral Medications for Type 2 Diabetes Mellitus
S. Bolen (2007)
Continuous Glucose Monitoring System in children with type 1 diabetes mellitus: a systematic review and meta-analysis
D. Golicki (2007)
Medical consequences of acromegaly: What are the effects of biochemical control?
A. Colao (2007)
Thyroid cancer in childhood: management
M Luster (2007)
Magnetic resonance imaging of thyroid cancer. Topics in magnetic resonance imaging
A Miyakoshi (2007)
Invited Commentary: US features of thyroid malignancy: pearls and pitfalls
J E Langer (2007)
Total thyroidectomy and adjuvant Page 56 of 95 T hy ro id D ow nl oa de d fr om o nl in e. lie be rt pu b. co m b y 80
D Handkiewicz-Junak (2007)
Total thyroidectomy and adjuvant
D Handkiewicz-Junak (2007)
Therapeutic impact of 18FDG-PET/CT in the management of iodinenegative recurrence of differentiated thyroid carcinoma. Surgery 142:952–958; discussion 952–958
E Mirallie (2007)
Thyroid cancer in children. Endocrinology and metabolism clinics of North America 36:779-806, vii
C Dinauer (2007)
Differentiated thyroid cancer in children and adults: same or distinct disease? Hormones (Athens) 6:200–209
B Jarzab (2007)
Total thyroidectomy and adjuvant Page 56 of 95 T hy ro id D ow nl oa de d fr om o nl in e. lie be rt pu b. co m b y C tr F or D is ea se C on tr ol o n 04
D Handkiewicz-Junak (2007)
Thyroid cancer in childhood: management strategy, 752 FRANCIS ET AL. including dosimetry and long-term results. Hormones (Athens) 6:269–278
M Luster (2007)
Sonographic imaging of thyroid nodules and cervical lymph nodes.
S. Fish (2008)
Hot Flashes and Subclinical Cardiovascular Disease: Findings From the Study of Women’s Health Across the Nation Heart Study
R. Thurston (2008)
A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly.
I. Holdaway (2008)
The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer.
A. P. Brown (2008)
Impact of treating acromegaly first with surgery or somatostatin analogs on cardiomyopathy.
A. Colao (2008)
Theories underlying health promotion interventions among cancer survivors.
B. Pinto (2008)
Guidelines for radioiodine therapy of differentiated thyroid cancer
M. Luster (2008)
High-Dose Statin Therapy for Secondary Prevention of Stroke: Stroke Prevention by Aggressive Reduction in Cholesterol Levels Study Review
D. Schwertz (2008)
Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS).
Y. Saitō (2008)
Recommendations for the use of LDL apheresis.
G. Thompson (2008)
Treatment of pituitary gigantism with the growth hormone receptor antagonist pegvisomant.
N. Goldenberg (2008)
Limited value of repeat recombinant human thyrotropin (rhTSH)-stimulated thyroglobulin testing in differentiated thyroid carcinoma patients with previous negative rhTSH-stimulated thyroglobulin and undetectable basal serum thyroglobulin levels.
M. Castagna (2008)
Chronic headache and pituitary tumors
M. Levy (2008)
Hypopituitarism following radiotherapy
K. Darzy (2008)
Hippocampal volumes are larger in postmenopausal women using estrogen therapy compared to past users, never users and men: A possible window of opportunity effect
C. Lord (2008)
Psychoeducational interventions to alleviate hot flashes: a systematic review
A. Tremblay (2008)
Recent advances in thyroid cancer.
E. Grubbs (2008)
Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin.
G. Heiss (2008)
Approach to the patient with a positive serum thyroglobulin and a negative radioiodine scan after initial therapy for differentiated thyroid cancer.
R. Kloos (2008)
Nicotinic acid, alone and in combinations, for reduction of cardiovascular risk.
B. G. Brown (2008)
Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.
K. Jamerson (2008)
Risk Factors for Lateral Cervical Lymph Node Involvement in Follicular Thyroid Carcinoma
H. Alfalah (2008)
Lipodystrophy in patients with acromegaly receiving pegvisomant.
V. Bonert (2008)
Intensive insulin therapy and pentastarch resuscitation in severe sepsis.
F. Brunkhorst (2008)
Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis.
P. Kearney (2008)
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.
P. Ridker (2008)
Thyroid nodules and cancers in children.
J. Josefson (2008)
Clinical and economic outcomes of thyroid and parathyroid surgery in children.
J. Sosa (2008)
Clinical use of cabergoline as primary and adjunctive treatment for acromegaly.
V. Moyes (2008)
Differential response of cholesterol and particle measures of atherogenic lipoproteins to LDL-lowering therapy: implications for clinical practice.
A. Sniderman (2008)
Prevalence of discordant GH and IGF-I levels in acromegalics at diagnosis, after surgical treatment and during treatment with octreotide LAR.
E. O. Machado (2008)
Growth hormone response during oral glucose tolerance test: the impact of assay method on the estimation of reference values in patients with acromegaly and in healthy controls, and the role of gender, age, and body mass index.
A. Arafat (2008)
Therapeutic Administration of 131I for Differentiated Thyroid Cancer: Radiation Dose to Ovaries and Outcome of Pregnancies
J. Garsi (2008)
Improvement of endothelial dysfunction in acromegaly after transsphenoidal surgery.
Haruna Sakai (2008)
Adult diffuse nesidioblastosis: genetically or environmentally induced?
G. Klöppel (2008)
Standards of Medical Care in Diabetes—2008
J. M. Dora (2008)
Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial
Gissi-Hf Investigators (2008)
Improved Contemporary Surgical Management of Insulinomas: A 25-year Experience at the Massachusetts General Hospital
M. Nikfarjam (2008)
Pediatric endocrine surgery: who is operating on our children?
C. Tuggle (2008)
Prevalence of vertebral fractures in men with acromegaly.
G. Mazziotti (2008)
Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction.
Zongliang Lu (2008)
Nutrition Recommendations and Interventions for Diabetes
J. Bantle (2008)
Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity.
M. Capezzone (2008)
Recombinant Human TSH–Assisted Radioactive Iodine Remnant Ablation Achieves Short-Term Clinical Recurrence Rates Similar to Those of Traditional Thyroid Hormone Withdrawal
R. M. Tuttle (2008)
The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004).
R. Wildman (2008)
Ultrasound screening for thyroid carcinoma in childhood cancer survivors: a case series.
E. Brignardello (2008)
Introducing a simplified approach to insulin therapy in type 2 diabetes: a comparison of two single‐dose regimens of insulin glulisine plus insulin glargine and oral antidiabetic drugs
M. R. Lankisch (2008)
Is nodule size an independent predictor of thyroid malignancy?
C. McHenry (2008)
Prevention of Hypoglycemia While Achieving Good Glycemic Control in Type 1 Diabetes
P. Rossetti (2008)
Clinical application of emerging sensor technologies in diabetes management: consensus guidelines for continuous glucose monitoring (CGM).
I. Hirsch (2008)
Effect of Glycemic Exposure on the Risk of Microvascular Complications in the Diabetes Control and Complications Trial—Revisited
J. Lachin (2008)
Impact of musculoskeletal disease on quality of life in long-standing acromegaly.
A. Miller (2008)
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial
S Yusuf (2008)
Management of the solitary thyroid nodule.
Meei J. Yeung (2008)
Lipoprotein Management in Patients With Cardiometabolic Risk
J. Brunzell (2008)
A systematic review of the gonadal effects of therapeutic radioactive iodine in male thyroid cancer survivors
A. Sawka (2008)
Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients.
E. Mills (2008)
Growth Hormone (GH) Treatment Does Not Restore Endothelial Function in Children with GH Deficiency
R. Hoffman (2008)
A systematic review examining the effects of therapeutic radioactive iodine on ovarian function and future pregnancy in female thyroid cancer survivors
Anna M. Sawka (2008)
Sleep apnoea syndrome is highly prevalent in acromegaly and only partially reversible after biochemical control of the disease.
M. Davi’ (2008)
Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): comparison of ezetimbe/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromes.
C. Cannon (2008)
Change of serum antithyroglobulin antibody levels is useful for prediction of clinical recurrence in thyroglobulin-negative patients with differentiated thyroid carcinoma.
W. Kim (2008)
Thyroid nodules and cancer in children and adolescents affected by autoimmune thyroiditis.
A. Corrias (2008)
A critical analysis of clinically available somatostatin analog formulations for therapy of acromegaly.
R. Murray (2008)
Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: the TNT (Treating to New Targets) study.
J. Shepherd (2008)
Alterations in body composition in acromegaly
L. Katznelson (2008)
Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: A synopsis of the National Cancer Institute Thyroid Fine‐Needle Aspiration State of the Science Conference
Z. Baloch (2008)
Evidence for the Role of Perioperative PTH Measurement after Total Thyroidectomy as a Predictor of Hypocalcemia
S. Grodski (2008)
EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry I: blood and bone marrow dosimetry in differentiated thyroid cancer therapy
M. Lassmann (2008)
Intragenic mutations in thyroid cancer.
M. Sobrinho-Simões (2008)
Impact of systemic hypertension on the cardiovascular benefits of statin therapy--a meta-analysis.
F. Messerli (2008)
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
A. Patel (2008)
carci - noma : results of a study on 1087 patients and review of the literature
SA Fish (2008)
Intragenic mutations in thyroid cancer. Endocrinology and metabolism clinics of North America 37:333-362, viii
M Sobrinho-Simoes (2008)
Measuring thyroglobulin and thyroglobulin autoantibody in patients with differentiated thyroid cancer. Nature clinical practice Endocrinology & metabolism 4:223-233
CA Spencer (2008)
Familial nonmedullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity. Endocrine-related cancer
M Capezzone (2008)
Measuring thyroglobulin and thyroglobulin autoantibody in patients with differentiated thyroid cancer
CA Spencer (2008)
Clinical and economic outcomes of thyroid and parathyroid surgery in children. The Journal of clinical endocrinology and metabolism 93:3058-3065
JA Sosa (2008)
F18-fluorodeoxyglucosepositron emission tomography/computed tomography screening in Li-Fraumeni syndrome
S Masciari (2008)
Recombinant thyrotropin use in children and adolescents with differentiated thyroid cancer: a multicenter retrospective study.
M. Luster (2009)
Management of hyperfunctioning single thyroid nodules in the era of minimally invasive thyroid surgery
C. Tan (2009)
Glucose control and vascular complications in veterans with type 2 diabetes.
W. Duckworth (2009)
Accuracy of fine-needle aspiration biopsy for predicting neoplasm or carcinoma in thyroid nodules 4 cm or larger.
S. Pinchot (2009)
Dosimetry-guided high-activity 131I therapy in patients with advanced differentiated thyroid carcinoma: initial experience
F. Verburg (2009)
Autonomous thyroid adenoma: only an adulthood disease?
K. Schwab (2009)
Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study
P. Sleight (2009)
Growth hormone deficiency is associated with decreased quality of life in patients with prior acromegaly.
T. Wexler (2009)
Colesevelam HCl effects on atherogenic lipoprotein subclasses in subjects with type 2 diabetes.
R. Rosenson (2009)
Combined treatment for acromegaly with long-acting somatostatin analogs and pegvisomant: long-term safety for up to 4.5 years (median 2.2 years) of follow-up in 86 patients.
S. Neggers (2009)
Cardiovascular risk markers during treatment with estradiol and trimegestone or dydrogesterone.
M. Hellgren (2009)
Follicular Thyroid Carcinoma in an Iodine-Replete Endemic Goiter Region: A Prospectively Collected, Retrospectively Analyzed Clinical Trial
R. Asari (2009)
Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort.
A. Meadows (2009)
Adherence to the DASH Diet Is Inversely Associated With Incidence of Type 2 Diabetes: The Insulin Resistance Atherosclerosis Study
A. Liese (2009)
Comparison of pegvisomant and long-acting octreotide in patients with acromegaly naïve to radiation and medical therapy
E. Ghigo (2009)
F18-Fluorodeoxyglucose–Positron Emission Tomography/Computed Tomography Screening in Li-Fraumeni Syndrome
J. Stockman (2009)
124I PET-Based 3D-RD Dosimetry for a Pediatric Thyroid Cancer Patient: Real-Time Treatment Planning and Methodologic Comparison
R. Hobbs (2009)
Renal and retinal effects of enalapril and losartan in type 1 diabetes.
M. Mauer (2009)
Differentiated thyroid carcinoma in pediatric patients: comparison of presentation and course between pre-pubertal children and adolescents.
L. Lazar (2009)
Postoperative PTH measurement facilitates day 1 discharge after total thyroidectomy
S. Grodski (2009)
Clinical effectiveness and cost-effectiveness of pegvisomant for the treatment of acromegaly: a systematic review and economic evaluation
D. Moore (2009)
The Bethesda System for Reporting Thyroid Cytopathology.
E. Cibas (2009)
Glucose tolerance and somatostatin analog treatment in acromegaly: a 12-month study.
A. Colao (2009)
Mutations in regulatory subunit type 1A of cyclic adenosine 5'-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes.
J. Bertherat (2009)
NCCN task force: clinical utility of PET in a variety of tumor types.
D. Podoloff (2009)
The successful use of sorafenib to treat pediatric papillary thyroid carcinoma.
S. Waguespack (2009)
The role of estrogen receptor subtypes for vascular maintenance
L. Luksha (2009)
Chromosome translocation frequency after radioiodine thyroid remnant ablation: a comparison between recombinant human thyrotropin stimulation and prolonged levothyroxine withdrawal.
A. Frigo (2009)
Outcomes of surgically managed pediatric thyroid cancer.
Anna E Bargren (2009)
Hormone therapy and risk of venous thromboembolism among postmenopausal women
M. Canonico (2009)
Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study
A. Astrup (2009)
Ten-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
R. Holman (2009)
Does amifostine have radioprotective effects on salivary glands in high-dose radioactive iodine-treated differentiated thyroid cancer
C. Ma (2009)
Consensus statement on the terminology and classification of central neck dissection for thyroid cancer.
S. Carty (2009)
Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.
D. Cooper (2009)
Rosuvastatin and cardiovascular events in patients undergoing hemodialysis.
B. Fellström (2009)
Postmenopausal hormone therapy and regional brain volumes
S. Resnick (2009)
De testimonio: on the evidence for decisions about the use of therapeutic interventions
M. Rawlins (2009)
Review of Motivational Interviewing in promoting health behaviors.
R. K. Martins (2009)
Pediatric thyroid fine-needle aspiration cytology: a meta-analysis.
C. Stevens (2009)
Is diabetes a coronary risk equivalent? Systematic review and meta‐analysis
U. Bulugahapitiya (2009)
The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials
J. Brugts (2009)
Increased burden of coronary artery disease in South-Asians living in North America. Need for an aggressive management algorithm.
K. Bainey (2009)
New therapeutic advances in the management of progressive thyroid cancer.
J. Woyach (2009)
The usual ultrasonographic features of thyroid cancer are less frequent in small tumors that develop after a long latent period after the Chernobyl radiation release accident.
V. Drozd (2009)
Comparison of efficacy and safety of atorvastatin (80 mg) to simvastatin (20 to 40 mg) in patients aged <65 versus >or=65 years with coronary heart disease (from the Incremental DEcrease through Aggressive Lipid Lowering [IDEAL] study).
M. Tikkanen (2009)
Pediatric differentiated thyroid carcinoma in stage I: risk factor analysis for disease free survival
N. Wada (2009)
Clinical behavior of radiation-induced thyroid cancer: factors related to recurrence.
Soe Naing (2009)
Preoperative staging of papillary thyroid carcinoma: comparison of ultrasound imaging and CT.
Ji Soo Choi (2009)
Recurrent laryngeal nerve monitoring: state of the art, ethical and legal issues.
P. Angelos (2009)
Ipsilateral Versus Bilateral Central Neck Lymph Node Dissection in Papillary Thyroid Carcinoma
T. Moo (2009)
Value of 18F-FDG-PET/PET-CT in differentiated thyroid carcinoma with radioiodine-negative whole-body scan: a meta-analysis
Meng-Jie Dong (2009)
Vasomotor symptoms and mortality: the Rancho Bernardo Study
J. Svartberg (2009)
Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: a systematic review and meta-analysis.
A. Sawka (2009)
Pediatric thyroid carcinoma: incidence and outcomes in 1753 patients.
A. Hogan (2009)
Limited effects of growth hormone replacement in patients with GH deficiency during long-term cure of acromegaly
A. A. van der Klaauw (2009)
Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control.
H. Rodbard (2009)
Effectiveness of self- or partner-administration of an extended-release aqueous-gel formulation of lanreotide in lanreotide-naïve patients with acromegaly
R. Salvatori (2009)
Insulin and the IGF system in the human placenta of normal and diabetic pregnancies
U. Hiden (2009)
Ezetimibe improves postprandial hyperlipidaemia in patients with type IIb hyperlipidaemia
D. Masuda (2009)
Mechanisms of action of estrogen receptors in vascular cells: relevance for menopause and aging
T. Simoncini (2009)
Long-Term Outcome in 215 Children and Adolescents with Papillary Thyroid Cancer Treated During 1940 Through 2008
I. Hay (2009)
Different cardiovascular effects of progestins according to structure and activity
A. Nath (2009)
Apolipoprotein B and cardiovascular disease risk: position statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices.
J. Contois (2009)
Treatment Strategy of Papillary Thyroid Carcinoma in Children and Adolescents: Clinical Significance of the Initial Nodal Manifestation
PhD Nobuyuki Wada MD (2009)
A Quality Control Study on Cytotechnologist-Cytopathologist Concordance and Its Relationship to the Number of Dots on the Slide
M. Bongiovanni (2009)
Diffuse sclerosing variant is a major subtype of papillary thyroid carcinoma in the young.
J. Koo (2009)
Suppressive effect of EPA on the incidence of coronary events in hypercholesterolemia with impaired glucose metabolism: Sub-analysis of the Japan EPA Lipid Intervention Study (JELIS).
S. Oikawa (2009)
Pattern recognition of benign nodules at ultrasound of the thyroid: which nodules can be left alone?
J. Bonavita (2009)
Salivary Gland Side Effects Commonly Develop Several Weeks After Initial Radioactive Iodine Ablation
R. Grewal (2009)
High-dose intramuscular octreotide in patients with acromegaly inadequately controlled on conventional somatostatin analogue therapy: a randomised controlled trial.
A. Giustina (2009)
Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials
K. Ray (2009)
Prevalence of GH deficiency in cured acromegalic patients: impact of different previous treatments.
C. Ronchi (2009)
Approach and safety of comprehensive central compartment dissection in patients with recurrent papillary thyroid carcinoma
G. Clayman (2009)
Ultrasound-guided fine-needle aspiration in the management of thyroid nodules in children and adolescents.
R. Izquierdo (2009)
Effect of Hot Flushes on Vascular Function: A Randomized Controlled Trial
P. Tuomikoski (2009)
Postoperative management of obstructive sleep apnea after transsphenoidal pituitary surgery.
L. Venkatraghavan (2009)
Clinical review: Hypoglycemia with intensive insulin therapy: a systematic review and meta-analyses of randomized trials of continuous subcutaneous insulin infusion versus multiple daily injections.
M. Fatourechi (2009)
Protecting thyroid cancer patients from untoward effects of radioactive iodine treatment.
R. Kloos (2009)
Thyroid Aspiration Cytology: Current Status
L. Layfield (2009)
Intubation in patients with acromegaly: experience in more than 800 patients.
Z. Khan (2009)
American Heart Association Childhood Obesity Research Summit Report.
S. Daniels (2009)
Performance of preoperative sonographic staging of papillary thyroid carcinoma based on the sixth edition of the AJCC/UICC TNM classification system.
J. Park (2009)
who receive radioactive iodine therapy
AM Sawka (2009)
RT Kloos (2009)
Value of 18F-FDG-PET/PET-CT in differentiated thyroid carcinoma with radioiodine-negative whole-body scan: a meta-analysis. Nuclear medicine communications 30:639-650
MJ Dong (2009)
Recurrent laryngeal nerve monitoring: state of the art, ethical and legal issues. The Surgical clinics of North America 89:1157-1169
P Angelos (2009)
Favourable course of disease after incomplete remission on 131I therapy in children with pulmonary metastases of papillary thyroid carcinoma: 10 years follow-up
J. Biko (2010)
Rosuvastatin for Primary Prevention in Older Persons With Elevated C-Reactive Protein and Low to Average Low-Density Lipoprotein Cholesterol Levels: Exploratory Analysis of a Randomized Trial
R. Glynn (2010)
Derivation and Validation of a New Cardiovascular Risk Score for People With Type 2 Diabetes
C. Elley (2010)
Papillary thyroid cancer in children and adolescents does not differ in growth pattern and metastatic behavior.
A. Machens (2010)
Repeated colonoscopic screening of patients with acromegaly: 15-year experience identifies those at risk of new colonic neoplasia and allows for effective screening guidelines.
D. Dworakowska (2010)
The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study
D. Bonds (2010)
Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease
A. Cass (2010)
Initiating Insulin as Part of the Treating To Target in Type 2 Diabetes (4-T) Trial
Nicholas Jenkins (2010)
Meta‐analysis of individual patient data to assess the risk of hypoglycaemia in people with type 2 diabetes using NPH insulin or insulin glargine
P. Home (2010)
The relationship between parental overprotection and health-related quality of life in pediatric cancer: the mediating role of perceived child vulnerability
S. Hullmann (2010)
Global variation in the pattern of differentiated thyroid cancer.
Stacey L Woodruff (2010)
Thyroid cancer in childhood: a retrospective review of childhood course.
C. O'Gorman (2010)
Central neck lymph node dissection for papillary thyroid cancer: the reliability of surgeon judgment in predicting which patients will benefit.
W. Shen (2010)
Outcomes of children and adolescents with well-differentiated thyroid carcinoma and pulmonary metastases following ¹³¹I treatment: a systematic review.
M. Pawelczak (2010)
Diminishing diagnosis of follicular thyroid carcinoma
K. Otto (2010)
Colesevelam lowers glucose and lipid levels in type 2 diabetes: the clinical evidence
V. Fonseca (2010)
Growth hormone deficiency after treatment of acromegaly: a randomized, placebo-controlled study of growth hormone replacement.
K. Miller (2010)
Multiple endocrine neoplasia type 1 (MEN1).
R. Thakker (2010)
Resistance Training in the Treatment of the Metabolic Syndrome
B. Strasser (2010)
Asian Americans and cardiometabolic risk why and how to study them.
M. Jacob (2010)
Serum Basal thyroglobulin measured by a second-generation assay correlates with the recombinant human thyrotropin-stimulated thyroglobulin response in patients treated for differentiated thyroid cancer.
C. Spencer (2010)
Effects of combination lipid therapy in type 2 diabetes mellitus.
H. Ginsberg (2010)
American Association of Clinical Endocrinologists Protocol for Standardized Production of Clinical Practice Guidelines--2010 update.
J. Mechanick (2010)
Endocrine aspects of obstructive sleep apnea.
P. Attal (2010)
Cost effectiveness of insulin glargine plus oral antidiabetes drugs compared with premixed insulin alone in patients with type 2 diabetes mellitus in Canada
S. Tunis (2010)
Randomized Clinical Trial of Quick-Release Bromocriptine Among Patients With Type 2 Diabetes on Overall Safety and Cardiovascular Outcomes
J. Gaziano (2010)
Female gonadal function before and after treatment of acromegaly.
M. Grynberg (2010)
American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules.
H. Gharib (2010)
Parental stress and perceived vulnerability at 5 and 10 years after pediatric SCT
C. M. J. Vrijmoet-Wiersma (2010)
Facilitation of β-cell KATP channel sulfonylurea sensitivity by a cAMP analog selective for the cAMP-regulated guanine nucleotide exchange factor Epac
C. Leech (2010)
Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants.
K. Ray (2010)
Hormone replacement therapy and the risk of venous thromboembolism: a population‐based study
C. Renoux (2010)
Preoperative lanreotide treatment in acromegalic patients with macroadenomas increases short-term postoperative cure rates: a prospective, randomised trial.
Z. Mao (2010)
Approach to the patient with persistent acromegaly after pituitary surgery.
L. Katznelson (2010)
Relation of different measures of low-density lipoprotein cholesterol to risk of coronary artery disease and death in a meta-regression analysis of large-scale trials of statin therapy.
J. Kizer (2010)
Thyroid cancer recurrence in patients clinically free of disease with undetectable or very low serum thyroglobulin values.
R. Kloos (2010)
Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial.
J. Armitage (2010)
Pulmonary fibrosis following radioiodine therapy of pulmonary metastases from differentiated thyroid carcinoma.
Libo Chen (2010)
Combination lipid therapy in type 2 diabetes.
F. Sacks (2010)
Levothyroxine Treatment in Pediatric Benign Thyroid Nodules
A. Corrias (2010)
Initial management and follow-up of differentiated thyroid cancer in children.
S. Waguespack (2010)
Pediatric thyroid fine-needle aspiration cytology: a meta-analysis
E. Eugster (2010)
Exposing the thyroid to radiation: a review of its current extent, risks, and implications.
B. Sinnott (2010)
Pediatric Graves’ Disease: Controversies in Management
S. Rivkees (2010)
Cardiovascular and Overall Mortality Risk in Relation to Alcohol Consumption in Patients With Cardiovascular Disease
S. Costanzo (2010)
Severe hypoglycemia and risks of vascular events and death.
S. Zoungas (2010)
Evidence of cognitive and neurophysiological impairment in patients with untreated naive acromegaly.
J. Leon-Carrion (2010)
Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women.
R. Chlebowski (2010)
Statins for primary prevention of cardiovascular mortality in women: a systematic review and meta-analysis.
R. N. Bukkapatnam (2010)
Cytotoxic chemotherapy for differentiated thyroid carcinoma.
S. Sherman (2010)
Complications of radioactive iodine treatment of thyroid carcinoma.
Stephanie L. Lee (2010)
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.
C. Baigent (2010)
Estrogen Receptors α and β Immunohistochemical Expression: Clinicopathological Correlations in Pituitary Adenomas
B. Manoranjan (2010)
Effects of intensive blood-pressure control in type 2 diabetes mellitus.
W. Cushman (2010)
Recurrence detection in differentiated thyroid cancer patients with elevated serum level of antithyroglobulin antibody: special emphasis on using 18F‐FDG PET/CT
J. H. Seo (2010)
Utilization of Total Thyroidectomy for Differentiated Thyroid Cancer in Children
M. Raval (2010)
Acromegaly and pregnancy: a retrospective multicenter study of 59 pregnancies in 46 women.
P. Caron (2010)
Empiric high-dose 131-iodine therapy lacks efficacy for treated papillary thyroid cancer patients with detectable serum thyroglobulin, but negative cervical sonography and 18F-fluorodeoxyglucose positron emission tomography scan.
W. Kim (2010)
A case‐control study on hormone therapy as a risk factor for breast cancer in Finland: Intrauterine system carries a risk as well
Heli K. Lyytinen (2010)
Tumor volume of growth hormone-secreting pituitary adenomas during treatment with pegvisomant: a prospective multicenter study.
J. Buhk (2010)
Effect of noninsulin antidiabetic drugs added to metformin therapy on glycemic control, weight gain, and hypoglycemia in type 2 diabetes.
O. Phung (2010)
Salivary gland malignancy and radioiodine therapy for thyroid cancer.
J. Klubo-Gwiezdzinska (2010)
Endothelial function and cardiovascular risk stratification in menopausal women
S. Mulvagh (2010)
Clinical and Pathological Factors Related to 18F-FDG-PET Positivity in the Diagnosis of Recurrence and/or Metastasis in Patients with Differentiated Thyroid Cancer
DipSci MBChB Dch Fracp MM Kevin London BHB (2010)
MRI versus (1)(3)(1)I whole-body scintigraphy for the detection of lymph node recurrences in differentiated thyroid carcinoma
J Mihailovic (2010)
MRI versus 131I whole-body scintigraphy for the detection of lymph node recurrences in differentiated thyroid carcinoma
J Mihailovic (2010)
Papillary thyroid cancer in children and adolescents does not differ in growth pattern and metastatic behavior. The Journal of pediatrics 157:648-652
A Machens (2010)
Recurrence detection in differentiated thyroid cancer patients with elevated serum level of antithyroglobulin antibody: special emphasis on using (18)F-FDG PET/CT. Clinical endocrinology 72:558-563
JH Seo (2010)
Dosimetry-guided high-activity (131)I therapy in patients with advanced differentiated thyroid carcinoma: initial experience. European journal of nuclear medicine and molecular imaging 37:896-903
FA Verburg (2010)
Trotti A (eds) AJCC Cancer Staging Manual
SB Thyroid. In Edge (2010)
Long-term outcome in 215 children and adolescents with papillary thyroid cancer treated during
ID Hay (2010)
Hürthle cell thyroid carcinoma presenting as a "hot" nodule.
Yalla Nm (2011)
Prognostic impact of serum thyroglobulin doubling-time under thyrotropin suppression in patients with papillary thyroid carcinoma who underwent total thyroidectomy.
A. Miyauchi (2011)
Angiotensin‐Converting Enzyme Inhibitor and Statin Use and Incident Mobility Limitation in Community‐Dwelling Older Adults: The Health, Aging and Body Composition Study
Shelly L. Gray (2011)
Consensus Report: The Current Role of Self-Monitoring of Blood Glucose in Non-Insulin-Treated Type 2 Diabetes
D. Klonoff (2011)
Oncofertility and preservation of reproductive capacity in children and young adults
W. Wallace (2011)
Clinical review: Clinical utility of thyroglobulin antibody (TgAb) measurements for patients with differentiated thyroid cancers (DTC).
C. Spencer (2011)
Fish consumption and CHD mortality: an updated meta-analysis of seventeen cohort studies
Jusheng Zheng (2011)
Employing Genetic Markers to Improve Diagnosis of Thyroid Tumor Fine Needle Biopsy
J. Cerutti (2011)
Hürthle cell thyroid carcinoma presenting as a "hot" nodule.
N. Yalla (2011)
Follicular thyroid carcinoma
M. Sobrinho-Simões (2011)
The treatment of differentiated thyroid cancer in children: emphasis on surgical approach and radioactive iodine therapy.
S. Rivkees (2011)
Blood Pressure Targets in Subjects With Type 2 Diabetes Mellitus/Impaired Fasting Glucose: Observations From Traditional and Bayesian Random-Effects Meta-Analyses of Randomized Trials
S. Bangalore (2011)
Prognosis and prognostic factors for distant metastases and tumor mortality in follicular thyroid carcinoma.
K. Sugino (2011)
Use of Twice-Daily Exenatide in Basal Insulin–Treated Patients With Type 2 Diabetes
J. Buse (2011)
Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis.
D. Preiss (2011)
Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials
G. Musso (2011)
The use of dosimetry in the treatment of differentiated thyroid cancer.
M. Lassmann (2011)
Papillary thyroid carcinoma in Peutz-Jeghers syndrome.
V. Triggiani (2011)
Risk-adapted management of differentiated thyroid cancer assessed by a sensitive measurement of basal serum thyroglobulin.
P. Malandrino (2011)
Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples.
Y. Nikiforov (2011)
Efficacy of preoperative neck ultrasound in the detection of cervical lymph node metastasis from thyroid cancer
Harry S. Hwang (2011)
Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial
K. Gadde (2011)
Suspiciously malignant findings on ultrasound after fine needle aspiration biopsy in a thyroid nodule with initially benign ultrasound and cytologic result: to repeat or to follow-up.
Yu-Mee Sohn (2011)
Hormone therapy and recurrence of venous thromboembolism among postmenopausal women
V. Olié (2011)
Health outcome prioritization as a tool for decision making among older persons with multiple chronic conditions.
T. Fried (2011)
Use of radioactive iodine for thyroid cancer.
M. Haymart (2011)
Effects of initiation and titration of a single pre-prandial dose of insulin glulisine while continuing titrated insulin glargine in type 2 diabetes: a 6-month ‘proof-of-concept’ study
D. Owens (2011)
Place of cabergoline in acromegaly: a meta-analysis.
Laure Sandret (2011)
Can 18F-FDG-PET/CT be generally recommended in patients with differentiated thyroid carcinoma and elevated thyroglobulin levels but negative I-131 whole body scan?
P. Bannas (2011)
Current concepts on coronary revascularization in diabetic patients.
M. Roffi (2011)
Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events.
D. Mozaffarian (2011)
Metformin sensitizes insulin signaling through AMPK‐mediated pten down‐regulation in preadipocyte 3T3‐L1 cells
SOO KYUNG Lee (2011)
Rising incidence of second cancers in patients with low‐risk (T1N0) thyroid cancer who receive radioactive iodine therapy
N. Iyer (2011)
Clinical characteristics and outcome of familial nonmedullary thyroid cancer: a retrospective controlled study.
E. Robenshtok (2011)
Historical note: TSH suppression for thyroid cancer.
J. Hurley (2011)
Effects of benefits and harms on older persons' willingness to take medication for primary cardiovascular prevention.
T. Fried (2011)
Bromocriptine: A Sympatholytic, D2-Dopamine Agonist for the Treatment of Type 2 Diabetes
R. DeFronzo (2011)
Cardiac care for older adults. Time for a new paradigm.
D. Forman (2011)
SPECT/CT imaging in children with papillary thyroid carcinoma
H. Kim (2011)
External Validation of an Index to Predict Up to 9‐Year Mortality of Community‐Dwelling Adults Aged 65 and Older
M. Schonberg (2011)
Long-term outcome of comprehensive central compartment dissection in patients with recurrent/persistent papillary thyroid carcinoma.
G. Clayman (2011)
The Chernobyl thyroid cancer experience: pathology.
V. Livolsi (2011)
Fibrates Effect on Cardiovascular Risk Is Greater in Patients With High Triglyceride Levels or Atherogenic Dyslipidemia Profile: A Systematic Review and Meta-analysis
E. Bruckert (2011)
Prevalence, clinicopathologic features, and somatic genetic mutation profile in familial versus sporadic nonmedullary thyroid cancer.
W. Moses (2011)
Predictive factors of malignancy in pediatric thyroid nodules.
Rashmi Roy (2011)
Clinical utility of inflammatory markers and advanced lipoprotein testing: advice from an expert panel of lipid specialists.
M. Davidson (2011)
Frequency of germline PTEN mutations in differentiated thyroid cancer.
R. Nagy (2011)
Serum phosphate predicts temporary hypocalcaemia following thyroidectomy
A. Sam (2011)
Statin myopathy: A common dilemma not reflected in clinical trials
Genaro Fernandez (2011)
Dipeptidyl peptidase‐4 inhibitors in the treatment of type 2 diabetes: a comparative review
C. Deacon (2011)
Positron emission tomography and positron emission tomography‐CT evaluation for recurrent papillary thyroid carcinoma: Meta‐analysis and literature review
M. Miller (2011)
Incidence and clinical characteristics of thyroid cancer in prospective series of individuals with Cowden and Cowden-like syndrome characterized by germline PTEN, SDH, or KLLN alterations.
J. Ngeow (2011)
The safety of combining angiotensin-converting-enzyme inhibitors with angiotensin-receptor blockers in elderly patients: a population-based longitudinal analysis
F. McAlister (2011)
Success of the postoperative 131I therapy in young Belarusian patients with differentiated thyroid cancer after Chernobyl depends on the radiation absorbed dose to the blood and the thyroglobulin level
H. Hänscheid (2011)
Approach to the pediatric patient with Graves' disease: when is definitive therapy warranted?
A. Bauer (2011)
Thyroid nodules and cancer in children with PTEN hamartoma tumor syndrome.
Jessica R Smith (2011)
Cardiovascular risk prediction in diabetic men and women using hemoglobin A1c vs diabetes as a high-risk equivalent.
N. Paynter (2011)
Analysis of prevalence and degree of macrocephaly in patients with germline PTEN mutations and of brain weight in Pten knock-in murine model
J. Mester (2011)
Molecular genetics and diagnosis of thyroid cancer
Y. Nikiforov (2011)
Follicular adenoma and carcinoma of the thyroid gland.
C. McHenry (2011)
Does an undetectable rhTSH‐stimulated Tg level 12 months after initial treatment of thyroid cancer indicate remission?
J. Klubo-Gwiezdzinska (2011)
Radiation safety in the treatment of patients with thyroid diseases by radioiodine 131I : practice recommendations of the American Thyroid Association.
J. Sisson (2011)
Postablation (131)I scintigraphy with neck and thorax SPECT-CT and stimulated serum thyroglobulin level predict the outcome of patients with differentiated thyroid cancer.
R. Ciappuccini (2011)
Thyroid cancer risk in Belarus among children and adolescents exposed to radioiodine after the Chornobyl accident
L. Zablotska (2011)
Current state and future perspective of molecular diagnosis of fine-needle aspiration biopsy of thyroid nodules.
C. Ferraz (2011)
Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy.
W. Boden (2011)
Thyroid surgery at Children's Hospital Boston: a 35-year single-institution experience.
S. Scholz (2011)
Pulmonary fibrosis in youth treated with radioiodine for juvenile thyroid cancer and lung metastases after Chernobyl
H. Hebestreit (2011)
Current state and future perspective of molecular diagnosis of fine-needle aspiration biopsy of thyroid nodules. The Journal of clinical endocrinology and metabolism 96:2016-2026
C Ferraz (2011)
Suspiciously malignant findings on ultrasound after fine ATA GUIDELINES FOR PEDIATRIC THYROID NODULES AND CANCER 749 D ow nl oa de d by
YM Sohn (2011)
Use of radioactive iodine for thyroid cancer. JAMA 306:721-728. Page 70 of 95 T hy ro id D ow nl oa de d fr om o nl in e. lie be rt pu b. co m b y 80
MR Haymart (2011)
Rising incidence of second cancers in patients with low - risk ( T 1 N 0 )
NG Iyer (2011)
Clinical Utility of Thyroglobulin Antibody (TgAb) Measurements for Patients with Differentiated Thyroid Cancers (DTC). The Journal of clinical endocrinology and metabolism 96:3615-3627
CA Spencer (2011)
Suspiciously malignant findings on ultrasound after fine ATA GUIDELINES FOR PEDIATRIC THYROID NODULES AND CANCER
YM Sohn (2011)
The comparison of (131)I whole-body scans on the third and tenth day after (131)I therapy in patients with well-differentiated thyroid cancer: preliminary report
JW Lee (2011)
Radiation safety in the treatment of patients with thyroid diseases by radioiodine Page 72 of 95 T hy ro id D ow nl oa de d fr om o nl in e. lie be rt pu b. co m b y 80
JC Sisson (2011)
Value of 131I SPECT/CT for the evaluation of differentiated thyroid cancer: a systematic review of the literature
Yan-li Xue (2012)
Relationship between hepatitis C virus infection and type 2 diabetes mellitus: meta-analysis.
C. Naing (2012)
All‐Cause 1‐, 5‐, and 10‐Year Mortality in Elderly People According to Activities of Daily Living Stage
M. Stineman (2012)
Cytomorphological and molecular genetic findings in pediatric thyroid fine‐needle aspiration
S. Monaco (2012)
Outcomes and prognostic factors of 251 patients with minimally invasive follicular thyroid carcinoma.
K. Sugino (2012)
Scoring system for predicting recurrences in patients with papillary thyroid microcarcinoma.
C. Buffet (2012)
Familial Follicular Cell-Derived Thyroid Carcinoma
E. Son (2012)
Long-term follow-up data may help manage patient and parent expectations for pediatric patients undergoing thyroidectomy.
L. Morris (2012)
Long-term clinical outcome of differentiated thyroid cancer patients with undetectable stimulated thyroglobulin level one year after initial treatment.
Ji Min Han (2012)
Combined intensive blood pressure and glycemic control does not produce an additive benefit on microvascular outcomes in type 2 diabetic patients.
F. Ismail-Beigi (2012)
Quality of life and anxiety in adolescents with differentiated thyroid cancer.
A. Oren (2012)
Preoperative diagnosis of benign thyroid nodules with indeterminate cytology.
E. Alexander (2012)
Meta-analysis of effect of dipeptidyl peptidase-4 inhibitors on cardiovascular risk in type 2 diabetes mellitus.
Harshal R. Patil (2012)
Long-term surveillance of papillary thyroid cancer patients who do not undergo postoperative radioiodine remnant ablation: is there a role for serum thyroglobulin measurement?
C. Durante (2012)
Basal insulin and cardiovascular and other outcomes in dysglycemia.
H. Gerstein (2012)
Radioactive iodine therapy
Stephanie L. Lee (2012)
In patients with thyroid cancer of follicular cell origin, a family history of nonmedullary thyroid cancer in one first-degree relative is associated with more aggressive disease.
H. Mazeh (2012)
Effect of Exercise on Blood Pressure in Type 2 Diabetes: A Randomized Controlled Trial
D. Dobrosielski (2012)
Recombinant human thyroid stimulating hormone-assisted radioactive iodine remnant ablation in thyroid cancer patients at intermediate to high risk of recurrence.
J. Hugo (2012)
Glycaemic efficacy of glucagon‐like peptide‐1 receptor agonists and dipeptidyl peptidase‐4 inhibitors as add‐on therapy to metformin in subjects with type 2 diabetes—a review and meta analysis
C. Deacon (2012)
The role of positron emission tomography and positron emission tomography/computed tomography in thyroid tumours: an overview
G. Treglia (2012)
Sequential Intensification of Metformin Treatment in Type 2 Diabetes With Liraglutide Followed by Randomized Addition of Basal Insulin Prompted by A1C Targets
J. DeVries (2012)
Medical Therapy for the Patient With Obesity
G. Bray (2012)
The prevalence of thyroid cancer and benign thyroid disease in patients with familial adenomatous polyposis may be higher than previously recognized.
E. Steinhagen (2012)
Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010.
K. Flegal (2012)
Ultrasonographic screening for thyroid cancer in siblings of patients with apparently sporadic papillary carcinoma.
P. Rosário (2012)
Undetectable sensitive serum thyroglobulin (<0.1 ng/ml) in 163 patients with follicular cell-derived thyroid cancer: results of rhTSH stimulation and neck ultrasonography and long-term biochemical and clinical follow-up.
A. Chindris (2012)
Quality of life in adolescent patients with differentiated thyroid cancer: moving beyond survival.
S. Mostoufi‐Moab (2012)
Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial
P. Ridker (2012)
Role of SPECT/CT in differentiated thyroid cancer
T. Barwick (2012)
Even without additional therapy, serum thyroglobulin concentrations often decline for years after total thyroidectomy and radioactive remnant ablation in patients with differentiated thyroid cancer.
R. Padovani (2012)
High-density lipoprotein particle number: a better measure to quantify high-density lipoprotein?
Emil M Degoma (2012)
Shared decision making--pinnacle of patient-centered care.
M. Barry (2012)
Thyrotropin and thyroid cancer diagnosis: a systematic review and dose-response meta-analysis.
D. Mcleod (2012)
Achieving Secondary Prevention Low-Density Lipoprotein Particle Concentration Goals Using Lipoprotein Cholesterol-Based Data
Simon C. Mathews (2012)
Age Patterns of Incidence of Geriatric Disease in the U.S. Elderly Population: Medicare‐Based Analysis
I. Akushevich (2012)
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials.
B. Mihaylova (2012)
American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis.
P. Jellinger (2012)
American Association of Clinical Endocrinologists' position statement on obesity and obesity medicine.
J. Mechanick (2012)
Complications of central neck dissection in patients with papillary thyroid carcinoma: results of a study on 1087 patients and review of the literature.
D. Giordano (2012)
Effect of saxagliptin as add-on therapy in patients with poorly controlled type 2 diabetes on insulin alone or insulin combined with metformin
A. Barnett (2012)
Quality of life in patients with thyroid cancer compared with the general population.
S. Singer (2012)
The value of diagnostic whole-body scanning and serum thyroglobulin in the presence of elevated serum thyrotropin during follow-up of anti-thyroglobulin antibody-positive patients with differentiated thyroid carcinoma who appeared to be free of disease after total thyroidectomy and radioactive iodin
P. Rosário (2012)
Strategies of radioiodine ablation in patients with low-risk thyroid cancer.
M. Schlumberger (2012)
GLP-1 agonists exenatide and liraglutide: a review about their safety and efficacy.
G. Derosa (2012)
Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study123
W. Garvey (2012)
Overview of molecular biomarkers for enhancing the management of cytologically indeterminate thyroid nodules and thyroid cancer.
D. Duick (2012)
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
S. Inzucchi (2012)
carcinoma who appeared to be free of disease after total thyroidectomy and radioactive iodine ablation
TD Barwick (2012)
PW Rosario (2012)
Quality of Life and Anxiety in Adolescents with Differentiated Thyroid Cancer. The Journal of clinical endocrinology and metabolism 97:E1933-1937
A Oren (2012)
cancer : a systematic review and meta - analysis
C Durante (2012)
Thyrotropin and thyroid cancer diagnosis: a systematic review and dose-response metaanalysis. The Journal of clinical endocrinology and metabolism 97:2682-2692
DS McLeod (2012)
Long-term follow-up data may help manage patient and parent expectations for pediatric patients undergoing thyroidectomy. Surgery 152:1165–1171
LF Morris (2012)
Indeterminate Pediatric Thyroid Fine Needle Aspirations: A Study of 68 Cases
M. Smith (2013)
Commentary on: Implications of thyroglobulin antibody positivity in patients with differentiated thyroid cancer: a clinical position statement.
C. Spencer (2013)
The current state of niacin in cardiovascular disease prevention: a systematic review and meta-regression.
Paul M. Lavigne (2013)
Clinical review: improving the measurement of serum thyroglobulin with mass spectrometry.
A. Hoofnagle (2013)
Minimally invasive follicular thyroid cancer (MIFTC)—a consensus report of the European Society of Endocrine Surgeons (ESES)
G. Dionigi (2013)
Mortality and Other Important Diabetes-Related Outcomes With Insulin vs Other Antihyperglycemic Therapies in Type 2 Diabetes
C. Currie (2013)
Ultrasensitive serum thyroglobulin measurement is useful for the follow-up of patients treated with total thyroidectomy without radioactive iodine ablation.
C. Nascimento (2013)
Twenty-five years after Chernobyl: outcome of radioiodine treatment in children and adolescents with very high-risk radiation-induced differentiated thyroid carcinoma.
C. Reiners (2013)
Approach to the patient: role of dosimetric RAI Rx in children with DTC.
F. Verburg (2013)
Frequency, Immunogenetics, and Clinical Characteristics of Latent Autoimmune Diabetes in China (LADA China Study)
Z. Zhou (2013)
Evolving approaches to patients with advanced differentiated thyroid cancer.
B. Haugen (2013)
Inhibition of the sodium glucose co‐transporter‐2: its beneficial action and potential combination therapy for type 2 diabetes mellitus
L. Chen (2013)
Differentiated thyroid carcinoma: defining new paradigms for postoperative management.
C. Durante (2013)
Thyroid cancer complicating familial adenomatous polyposis: mutation spectrum of at-risk individuals
S. Septer (2013)
The noninvestigational use of tyrosine kinase inhibitors in thyroid cancer: establishing a standard for patient safety and monitoring.
Aubrey A. Carhill (2013)
Support of personalized medicine through risk-stratified treatment recommendations - an environmental scan of clinical practice guidelines
T. Yu (2013)
Implications of thyroglobulin antibody positivity in patients with differentiated thyroid cancer: a clinical position statement.
F. Verburg (2013)
Postoperative-stimulated serum thyroglobulin measured at the time of 131I ablation is useful for the prediction of disease status in patients with differentiated thyroid carcinoma.
Ji In Lee (2013)
Diagnostic value of thyroglobulin assay in cervical lymph node fine-needle aspirations for metastatic differentiated thyroid cancer
L. Giovanella (2013)
Canagliflozin, a new sodium-glucose cotransporter 2 inhibitor, in the treatment of diabetes.
S. Nisly (2013)
Refocusing the agenda on cardiovascular guidelines: an announcement from the National Heart, Lung, and Blood Institute.
G. Gibbons (2013)
Cowden syndrome and the PTEN hamartoma tumor syndrome: systematic review and revised diagnostic criteria.
R. Pilarski (2013)
Spectrum and Risk of Neoplasia in Werner Syndrome: A Systematic Review
J. Lauper (2013)
Preoperative cytology with molecular analysis to help guide surgery for pediatric thyroid nodules.
Melissa A Buryk (2013)
Endocrine tumors associated with neurofibromatosis type 1, Peutz-Jeghers syndrome and other familial neoplasia syndromes.
Esra Kalkan (2013)
Adult-Onset Autoimmune Diabetes in Europe Is Prevalent With a Broad Clinical Phenotype
M. Hawa (2013)
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
C. Yancy (2013)
Thyroid Nodules (≥4 cm): Can Ultrasound and Cytology Reliably Exclude Cancer?
Laura I. Wharry (2013)
Thyroid Ultrasound Findings in Children from Three Japanese Prefectures: Aomori, Yamanashi and Nagasaki
N. Hayashida (2013)
Statins for the primary prevention of cardiovascular disease.
F. Taylor (2013)
HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment
R. Haynes (2013)
A standardized assessment of thyroid nodules in children confirms higher cancer prevalence than in adults.
A. Gupta (2013)
The next steps in developing clinical practice guidelines for prevention.
G. Gibbons (2013)
Cowden syndrome and the PTEN 748 FRANCIS ET AL. hamartoma tumor syndrome: systematic review and revised diagnostic criteria
R Pilarski (2013)
Cowden syndrome and the PTEN
R Pilarski (2013)
Commentary on: Implications of thyroglobulin antibody positivity in patients with differentiated thyroid cancer: a clinical position paper. Thyroid 23:11901192
CA Spencer (2013)
Commentary on: Implications of thyroglobulin antibody positivity in patients with differentiated thyroid cancer: a clinical position paper. Thyroid 23:1190–1192
CA Spencer (2013)
A standardized assessment of thyroid nodules in children confirms Page 57 of 95 T hy ro id D ow nl oa de d fr om o nl in e. lie be rt pu b. co m b y C tr F or D is ea se C on tr ol o n 04
A Gupta (2013)
A standardized assessment of thyroid nodules in children confirms Page 57 of 95 T hy ro id D ow nl oa de d fr om o nl in e. lie be rt pu b. co m b y
A Gupta (2013)
KAe. SEER Cancer Statistics Review, 1975-2010, based on November 2012 SEER data submission, posted to the SEER web
N Howlader (2013)
Differentiated thyroid carcinoma: defining new paradigms for postoperative management. Endocrine-related cancer 20:R141-154
C Durante (2013)
Value of (1)(3)(1)I SPECT/CT for the evaluation of differentiated thyroid cancer: a systematic review of the literature. European journal of nuclear medicine and molecular imaging 40:768-778
YL Xue (2013)
Non-pheochromocytoma (PCC)/paraganglioma (PGL) tumors in patients with succinate dehydrogenase-related PCC-PGL syndromes: a clinicopathological and molecular analysis.
T. Papathomas (2014)
Response to sorafenib in a pediatric patient with papillary thyroid carcinoma with diffuse nodular pulmonary disease requiring mechanical ventilation.
Increase in the incidence of differentiated thyroid carcinoma in children, adolescents, and young adults: a population-based study.
L. Vergamini (2014)
L. Doros (2014)
Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial
M. Brose (2014)
Response to sorafenib in a pediatric patient with papillary thyroid carcinoma with diffuse nodular pulmonary disease requiring mechanical ventilation.
Pallavi Iyer (2014)
Is empirical radioactive iodine therapy still a valid approach to patients with thyroid cancer and elevated thyroglobulin?
P. Rosário (2014)
Tenth Warren K. Sinclair Keynote Address—The Fukushima Nuclear Power Plant Accident and Comprehensive Health Risk Management
S. Yamashita (2014)
Pediatric endocrine surgery: a 20-year experience at the Mayo Clinic.
A. Kundel (2014)
Exploring the association Between DICER1 mutations and differentiated thyroid carcinoma.
L. de Kock (2014)
Sorafenib in radioactive iodinerefractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial
MS Brose (2014)
Nonpheochromocytoma (PCC)/paraganglioma (PGL) tumors in patients with succinate dehydrogenase-related PCCPGL syndromes: a clinicopathological and molecular analysis
TG Papathomas (2014)
Nonpheochromocytoma (PCC)/paraganglioma (PGL) tumors in patients with succinate dehydrogenase-related PCC-PGL syndromes: a clinicopathological and molecular analysis
TG Papathomas (2014)
Calsolari MR 2014 Is empirical radioactive iodine therapy still a valid approach to patients with thyroid cancer and elevated thyroglobulin? Thyroid 24:533–536
PW Rosario (2014)
Is Stimulated Thyroglobulin Necessary after Ablation in All Patients with Papillary Thyroid Carcinoma and Basal Thyroglobulin Detectable by a Second-Generation Assay?
P. Rosário (2015)
Lenvatinib versus placebo in radioiodine-refractory thyroid cancer.
M. Schlumberger (2015)
Are we really at the dawn of understanding sporadic pediatric thyroid carcinoma?
M. I. V. Cordioli (2015)
Conservative or radical surgery for pediatric papillary thyroid carcinoma: A systematic review of the literature.
X. Jin (2015)
Evaluating the Rare and Predicting the Worst: Lessons for Thyroid Nodules.
S. Rivkees (2015)
Inaugural Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer: Children Are Not Small Adults.
S. Lafranchi (2015)
U. S. Preventive Services Task Force Ratings (2015)
This paper is referenced by
Factors Influencing Cervical Lymph Node Metastasis in Pediatric Differentiated Thyroid Cancers
S. Qureshi (2021)
Association of same-day discharge with hospital readmission after pediatric thyroidectomy
Jasmine Bhinder (2021)
Laryngeal Neural Monitoring during Pediatric Thyroid Cancer Surgery—Is Transcartilage Recording a Preferable Method?
Tzu-Yen Huang (2021)
An Adolescent with Papillary Thyroid Carcinoma and Locally Metastatic Disease but No Distant Metastases
Sarah J. Bottomley (2021)
Management of benign paediatric thyroid nodules: experience from paediatric ENT services of a tertiary care hospital
A. Chakravarti (2021)
Levothyroxine and Cancer
T. Bednarczuk (2021)
[Clinical practice guidelines "Management of iodine deficiency disorders"].
F. М. Abdulkhabirova (2021)
Molecular Alterations in Relation to Histopathological Characteristics in a Large Series of Pediatric Papillary Thyroid Carcinoma from a Single Institution
E. Macerola (2021)
Prevalence of thyroid malignancy and hormonal dysfunction following radiation exposure in childhood.
Y. Tiong (2021)
Understanding of Pulmonary Metastases in Pediatric Patients with Differentiated Thyroid Cancer Is Evolving
Kara D Meister (2021)
Recombinant human thyroid‐stimulating hormone versus thyroid hormone withdrawal preparation for radioiodine ablation in differentiated thyroid cancer in children, adolescents and young adults
Max A Schumm (2021)
Radioactive Iodine uptake in the breast tissue of Nulliparous adolescent girls and young women
A. Sher (2021)
Comparison of Surgical Outcomes between Robotic Transaxillary and Conventional Open Thyroidectomy in Pediatric Thyroid Cancer
In A Lee (2021)
Co-occurrence of bilateral intrathyroidal parathyroid gland and papillary thyroid carcinoma; a case report
Ari M. Abdullah (2021)
Employing caution when applying the American College of Radiology Thyroid Imaging Reporting and Data System for pediatric thyroid nodule management
Marla B. K. Sammer (2021)
Incidence of Recurrent Differentiated Thyroid Carcinoma in Paediatrics and Adolescents after Thyroid Surgery: A Meta-Analysis Study of Last 20 Years
M. B. A. M. AYMAN A. ALBAGHDADY, M.D. (2021)
A synchronous papillary and follicular thyroid carcinoma presenting as a large toxic nodule in a female adolescent
J. Van Vlaenderen (2020)
Paediatric Molecular Radiotherapy: Challenges and Opportunities.
M. Aldridge (2020)
Outpatient thyroidectomy in the pediatric population.
Sophie Dream (2020)
BRAF V600E and TERT promoter mutations in paediatric and young adult papillary thyroid cancer and clinicopathological correlation
D. Chakraborty (2020)
Reduction of Salivary Gland Damage During Radioiodine Therapy for Differentiated Thyroid Cancers
B. Ahn (2020)
Thyroid surgery in 103 children in a single institution from 2000-2014
O. Almosallam (2020)
Patterns and Predictors of Metastatic Spread to the Neck in Pediatric Thyroid Carcinoma
E. Propst (2020)
A Japanese Family with DICER1 Syndrome Found in Childhood-Onset Multinodular Goitre
K. Nagasaki (2020)
Thyroid Uptake and Scan
A. Iqbal (2020)
Current Image-Guided Interventions in Pediatric Surgery.
Nathan S. Rubalcava (2020)
A case series and review on pediatric thyroid nodules
Anju P Sukumaran (2020)
Risk of structural persistent disease in pediatric patients with low or intermediate risk differentiated thyroid cancer
M. Klain (2020)
Invited Commentary: Clinical Assessment of Pediatric Patients with Differentiated Thyroid Carcinoma: A 30-Year Experience at the Single Institution
Danielle I Ellis (2020)
Pediatric thyroid ultrasound: a radiologist’s checklist
I. Tritou (2020)
Thyroid Disorders in Adolescence
Esra Karslioglu-French (2020)
Clinical Assessment of Pediatric Patients with Differentiated Thyroid Carcinoma: A 30-Year Experience at a Single Institution
Kwangsoo Kim (2020)See more